Team:Freiburg/Notebook/method

From 2013.igem.org

(Difference between revisions)

Latest revision as of 19:50, 28 October 2013

uniBAss - uniCAS Binding Assay Notebooks

May

15.05.13

Digest with BbsI

µl	type
8	pX334a (243ng/µl)
2µl	NEB-Buffer 2.1
1µl	BbsI
Add to 50µl	H₂O

pX334a was digested for 2h at 37°C using BbsI for subsequent target insertion.

Gel extraction of the digested pX334a

Bands were cut out and extracted with Roche high pure PCR product purification kit. Eluation in 20µl H₂O, before centrifugation: incubated 10min at room temp. Eluted liquid put on column again, incubated for 10 min and centrifuged. concentrations: less than 16.5ng/µl.

Ligation of digested pX334a with annealed oIG9007-oIG9008 (EMX1 locus)

µl	type
2.5	pX334a (16.5 ng/µl)
1µl	T4 ligase buffer
0.5µl	T4 ligase

Five different ligation mixes (dilution row of insert, 1x, 10x 100x ,500x, 1000x diluted insert) + the negative control with water instead of oligo were incubated for 1h at 22°C. This resulted in pIG9000.

Transformation of Top10 E. coli with the pX334a containing the EMX1 locus (pIG9000)

The 6 different samples were transformed following the protocol and were thus given on an agar plate with Ampicilline and incubated over night.

16.05.13

Picking colonies and streakout

The negative control showed five colonies whereas the plate with 1x duluted insert had 12 colonies, 10x had 17 colonies, 100x had 17 colonies, 500 had 10 colonies, 1000x hat 18 colonies. From each of the two plates with the most colonies were 8 colonies picked. 16ten streakouts were performed on AMP agar plates and incubated over night at 37°C.

17.05.13

Miniprep and testdigest

The miniprep was performed as stated in the protocol. Afterwards a testdigest was performed.

Testdigest of 16. possible pIG9000 colonies, mastermix contained

µl	type
total 40µl	Sample
4µl	BbsI
4µl	NcoI
20µl	NEB 2.1
132µl	H2O

After 2h at 37°C the samples were applied on an agarose gel (1% Agar, 0.5 TAE to 50 ml) to visualize band 3 ul gel red was used. The gel displayed that some colonies showed no additional band and therefore are likely to have the insert included. Those positive minipreps were send to sequencing at GATC.

The sequencing results validated that the insert was successfully cloned into pX334a and therefore pIG9000 was ready for the testing on the ELISA.

18.05.13

Oligoannealing and transformation of E. coli with pIG9000 with the aim the perform a midi prep

The oligoannealing with the biotinylated oligonucleotides oIG9000, oIG9001 and oIG9002 was performed at 95°C for 5 minutes, afterwards the heating block was turned off. The transformation was performed following the protocol. The transformed cells were given into 150ml LB-media containing AMP and were incubated overnight at 37°C.

19.05.13

Performing a midiprep

A midiprep of the E. coli containing pIG9000 was performed following the protocol. Result: 2487ng/µl in a volume of 200µl.

20.05.13

Seeding cells for transfection

HEK-293T cells were seeded at a density of 250,000 cells/ml. The conservation culture contained 60,000 cells/ml.

Human embryonic kidney cells (HEK-293T) were cultivated in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10 % Fetal Calf Serum (FCS) and 1 % penicillin / streptomycin solution (DMEM complete) and incubated in a moisturized atmosphere containing 5 % CO2. Cells were detached with 2.4 ml Trypsin-EDTA solution, transferred into 7 ml fresh medium and centrifuged for 3 min at 900 x g. The supernatant was removed and the pelleted cells were resuspended in 5 - 7 ml medium. Cell numbers were determined by transferring 100µl cell solution to 10 ml of Casyton Buffer and counted in an Innovatis Casy Cell counter (Casy-Technology, Reutlingen, Germany, model TT). For maintaining cultures, HEK-293T cells were cultivated in petridishes with a starting concentration of 0.6 or 1.2*106 cells in 10 ml medium and incubated as described before.

21.05.13

Contamination & seeding cells

Contamination occured therefore the cells had to be seeded again following the protocol.

23.05.13

PEI Transfection and preparation of uniBAss experiment

Seeded cells were transfected with pIG9000 following the protocol.
Cells were transfected using the PEI transfection method with the following concentrations: Typically for a 200µl transfection mix, 1.5µg of DNA and 5µl PEI (Polysciences, Inc., PA, cat. no. 23966) were filled up with OptiMEM (Invitrogen GmbH, Darmstadt, Germany cat. no. 11058-021) to 100µl. Afterwards, the 100µl PEI solution was added to the 100µl DNA solution, vortexed and incubated at RT for 15 to 30 min. Afterwards 200µl of the PEI / DNA transfection mix was added drop-wise to each 1 ml culture medium containing cells in well plates and incubated at 37°C, 5 % CO2. After 5 h, the medium was exchanged , Dulbecco's modified Eagle's medium (DMEM), supplemented with 10 % Fetal Calf Serum (FCS) and 1 % penicillin / streptomycin solution (DMEM complete)

The ELISA plates (Corning, Inc., cat. no. 3590, NY, New York) were coated with 100µl streptavidin solution (20µl / 10 ml in dH₂0 to obtain a final concentration of 4µg/ml) and incubated overnight at 4°C.

24.05.13

uniBAss experiment to observe the influence of different Ion concentrations

The streptavidin coated plates were washed 3 x with TBST (TBS, 2 ml / l Tween20) and 300µl blocking buffer (1 x TBST, 1 % BSA) was added for 1 h. After 3 x washing with TBST, the biotinylated oligonucleotides (10pmol/well) were applied and incubated at RT for 1 h. Afterwards the plates were washed 3 x with TBST. To obtain the cell lysate with the Cas9 protein, the transfected HEK-293T cells (250,000 cells / ml) were resuspended in 250µl dilution buffer (10 mM Tris, 1 % BSA, 10 mM MgCl2, 10 mM NaCl) containing EDTA free Protease inhibitor per 125,000 cells / ml and sonified for 10 min. To remove the cell fractions the lysate was centrifuged for 5 min at 500xg.

To adjust the buffer condition a dilution row with cell lysate comprising the Cas9 were performed in round 96-well plates. The dilution buffers used were b1 (10 mM Tris, 1 % BSA, 10 mM MgCl2, 250 mM NaCl) and b2 (10 mM Tris, 1 % BSA, 100 mM MgCl2, 10 mM NaCl) respectively. This resulted in the following conditions.

MgCl2 [mM]	NaCl [mM]
10	250
10	125
10	62.5
10	31.25
10	15.62
10	7.81
10	3.9
10	1.95
10	0.97
10	0.48

NaCl [mM]	MgCl2 [mM]
10	100
10	50
10	25
10	12.5
10	6.25
10	3.12
10	1.56
10	0.89
10	0.39
10	0.19

Afterwards 100µl of the diluted cell lysate was transferred to the ELISA plates. After 1 h incubation at RT the plates were washed 3 x with TBST and 100µl anti-HA antibody solution (1000 x diluted in blocking buffer) was applied to each wells and incubated for 1 h. After 3 x washing with TBST, 100µl anti-mouse HRP antibody (4000 x diluted in blocking buffer,) were added. After 1 h incubation, plates were washed 3 x with TBST, probed with 100µl ELISA ABTS substrate and the absorbance was measured at 405 nm. For the positive controls, wells were coated with 100µl FM protein (1.0 µg / ml) and directly with the sonificated cell lysate in the dilution buffer. The negative controls performed were composed of, no Antibody, no oligonucleotide at all, not the matching oligonucleotide sequence.

in the following this protocol was always used only variations are mentioned.

Result: Figure 1

Binding restrain of the Cas9 MX1 crRNA complex for bisected buffer

To check if the Cas9 protein was in the cell lysate a western blot was performed

For specific detection of proteins, semi-dry Western Blots were performed. The polyvinylidene fluoride membrane (PVDF) (0.45 µm, Millipore Corporation, Bedford, MA, cat. no. T831.1) was first activated in methanol then washed with dH₂O and subsequently equilibrated in the transfer buffer. For Semi-dry transfer of proteins, a sandwich of Whatman paper / gel / membrane / Whatman paper (wetted with the transfer buffer) is placed directly between cathode and anode in a blotting chamber (Peqlab, Biotechnologie GmbH, Erlangen, Germany cat. no. 52-2020). The blot was performed at 450 mA for 1 h. To prevent unspecific binding of antibodies, the membrane was incubated in block ing solution (2 % milk in PBST) at room temperature for 1 h at shaking conditions. Afterwards, the membrane was incubated in PBST 1 % milk supplemented with the primary antibody at room temperature for 1 h. Followed by washing the membrane 3 x with PBST for 15 min, the membrane was incubated with PBST 1 % milk containing a horse radish peroxidase (HRP) conjugated secondary antibody at room temperature for 1 h. After 3 x washing with PBST for 10 - 15 min, the blot was incubated with 1 ml Western Blotting Detection Solution and detection of the chemiluminescence, emanating from the HRP-mediated conversion of the substrate was performed in an image reader .

June

05.06.13

Seeding cells for PEI transfection

The seeding of the cell was done as mentioned above.

06.06.13

PEI transfection and coating of ELISA plate

The seeding of the cell was done as mentioned above

07.06.13

Testing the best oligonucleotide length for Cas9/crRNA binding

The three different biotinylated and annealed oligonucleotides oIG9000 / oIG9001, oIG9002 / oIG9003 and oIG9004 / oIG9005 (10 pmol / well) were coated by incubation at RT for 1 h. The transfected HEK-293T cells (250,000 cells / ml) were harvested by sonification for 10 minutes in the dilution buffer (10 mM Tris, 1 % BSA, 125 mM NaCl, 10 mM MgCl2) and (10 mM Tris, 1 % BSA, 50 mM MgCl2, 10 mM NaCl) containing one tablet of the EDTA free Protease inhibitor cocktail per 50 ml buffer. The Buffer dilution comprising the Cas9 were performed in round 96-well plates by a 1:1.

NaCl [mM]	MgCl2 [mM]
125	50
125	25
125	12.5
125	6.25
125	10
10	50

The results show that a total length of 40 nucleotides is not enough for the Cas9 / RNA to bind. 50 nucleotides are sufficient for binding however 60 nucleotides show the most robust binding behaviour.

12.06.13

Seeding cells for PEI transfection

The seeding of the cell was done as mentioned above.

13.06.13

PEI transfection and coating of ELISA plate

The PEI transfection and coating of the ELISA plate was done as mentioned above.

14.06.13

Optimizing the buffer condition

Different concentrations of MgCl2 – 30 mM, 20 mM, 10 mM and 5 mM – and of NaCl – 150 mM, 120 mM, 90 mM and 60 mM, were varied against each other.

The ELISA was performed as explained above. Dilution buffers containing (10 mM Tris, 1 % BSA, NaCl – 150 mM, 120 mM, 90 mM and 60 mM, MgCl2 – 30 mM, 20 mM, 10 mM and 5 mM respectivly) containing one tablet EDTA free Protease inhibitor cocktail per 50 ml were used to uptake the transfected HEK–293T cells and subsequently perform cell lysis.

NaCl [mM]	MgCl2 [mM]
150	30
150	20
150	10
150	5

NaCl [mM]	MgCl2 [mM]
120	30
120	20
120	10
120	5

NaCl [mM]	MgCl2 [mM]
90	30
90	20
90	10
90	5

NaCl [mM]	MgCl2 [mM]
60	30
60	20
60	10
60	5

The figure shows that the binding behaviour of the Cas9 / crRNA towards EMX1 display similar behaviour for descending MgCl2. This is true for all four NaCl concentrations however 150 mM NaCl has the smallest yield.

17.06.13

Seeding cells for PEI transfection

The seeding of the cell was done as mentioned above.

18.06.13

PEI transfection and coating of ELISA plate

The PEI transfection was performed with the corresponding plasmids and coating of the ELISA plate was done as mentioned above.

19.06.13

Testing of dCas9 – VP16 fusion proteins in different buffer conditions

The ELISA was performed as mentioned above. The transfected HEK–293T cells were harvested using the dilution buffers with varying NaCl and varying MgCl2 contrations (10 mM Tris, 1 % BSA, 150 mM, 120 mM, 90 mM or 60 mM NaCl and 20 mM, 10 mM or 5 mM MgCl2) containing EDTA free Protease inhibitor.

NaCl [mM]	MgCl2 [mM]
150	5
120	20
120	10
120	5
90	5
60	5

Three different VEGF crRNA targets of Cas9 - VP16. The binding affinity of the Cas9 – crRNA complex was analysed during an ELISA. The figure shows that for different crRNAs the binding affinities differs. The best binding condition was obtained with 5 mM MgCl2 and 90 mM NaCl. The error bars represent the standard deviation of 3 replicas.

23.06.13

Seeding cells for PEI transfection

The seeding of the cell was done as mentioned above.

24.06.13

PEI transfection and coating of ELISA plate

The PEI transfection was performed with the corresponding plasmids and coating of the ELISA plate was done as mentioned above.

25.06.13

Testing of different dCas9 fusion proteins in the optimized buffer condition.

The tested constructs can be divided into two groups. The Cas9 fusion constructs Cas9 - VP16, Cas9 - KRAB and the Cas9 with one active nickase domain and with two nickase domains. The composition of this experiment aimed to examine whether all constructs are expressed in the same pace and display the same binding behavior.

The ELISA was performed as explained. The ELISA indicated that the fusion constructs are 3 - fold less expressed than the constructs with the Cas9 only. The comparison between a Cas9 completely lacking the nickase activity and a Cas9 having one active nickase shows no significant difference. However the yield of the Cas9 construct without any nicking activity is slightly higher. A Bradford assay was used to adjust the FM protein concentration for the standard. The FM protein was coated in a 1 : 1 dilution row for 1 h at RT in duplicates onto the ELISA plate. The transfected HEK–293T cells were harvested using the optimized dilution buffer (10 mM Tris, 1 % BSA, 90 mM NaCl, 5 mM MgCl2) containing EDTA free Protease inhibitor.

The four different biotinylated and annealed oligonucleotides (oIG9004 / oIG9005, oIG9012 / oIG9013, oIG9041 / oIG9042 and oIG9015 / oIG9016 (10 pmol / well) were coated by incubation at RT for 1 h. After 24 h transfected HEK-293T cells were resuspended in the optimized buffer condition and the binding affinity of the different Cas9 / crRNA construct was analysed during an ELISA. A quantification of the different Cas9 constructs was performed by using a standard dilution row with FM protein. a) Concentration of the undiluted Cas9 constructs. The figure shows the different quantities of different Cas9 constructs as well as the disparity of undiluted sample compared to diluted samples. Error bars represent the standard deviation of 3 replicas.

The four different biotinylated and annealed oligonucleotides (oIG9004 / oIG9005, oIG9012 / oIG9013, oIG9041 / oIG9042 and oIG9015 / oIG9016 (10 pmol / well) were coated by incubation at RT for 1 h. After 24 h transfected HEK-293T cells were resuspended in the optimized buffer condition and the binding affinity of the different Cas9 / crRNA construct was analysed during an ELISA. A quantification of the different Cas9 constructs was performed by using a standard dilution row with FM protein. Concentration of the 1:1 diluted Cas9 constructs. The figure shows the different quantities of different Cas9 constructs as well as the disparity of undiluted sample compared to diluted samples. Error bars represent the standard deviation of 3 replicas.

Quantification of Cas9 via HA-tagged FM protein

to quantify the amount of Cas9 with uniBAss HA-tagged FM protein with known protein concentration. like this we were abele to performe a dilution row to get a standard to convert the ABTS readout in ng protein bound in the ELISA.

graph showing the standard curve for quantification of HA-tagged protein in the uniBAss ELISA

To convert the ABTS readout of uniBAss with our Cas9 and dCas9 the formula y = 0,0793x + 0,0255 was used. Like this we succeded in receiving absolut ng of dCas9 with our ELISA.

Quantification of different Cas9 and dCas9 constructs

July

23.07.13

PCR Cas9

µl	type
10	Q5-HF Reaction Buffer
1	Template: pIG2004
1	oIG9100
1	oIG9101
4	dNTPs
1	DMSO
0,5	Q5-HF Polymerase
Add to 50	H₂O

Annealing: 60°C
Extension: 2min20sec
18 cycles

Roth 1kb ladder - Cas9-PCR a - Cas9-PCR b - 2log ladder NEB
There is a second (unspecific?) band in b.

Gel extraction of PCR Cas9

Bands a and b were cut out and extracted separately with Roche high pure PCR product purification kit. Eluation in 20 µl H₂O, before centrifugation: incubated 10min at room temp. Eluted liquid put on column again, incubated for 10 min and centrifuged. concentrations: less than 5ng, no digest performed. -> repeat PCR tomorrow.

24.07.13

PCR Cas9

PCR was repeated with same program but 25 cycles instead of 18. This time no unspecific bands were visible (picture could not be saved). Both bands were cut out and extracted over same column with Roche Kit.
Concentration: 65 ng/µl

Digest with SacII and KpnI-HF

µl	type
10	pIG6000 (170ng/µl=1.7µg)
2µl	NEB-Buffer Cut-Smart
1µl	SacII
1µl	KpnI-HF
Add to 20 µl	H₂O

µl	type
25	Cas9-PCR (65 ng/µl=1,625µg)
5µl	NEB-Buffer Cut-Smart
1µl	SacII
1µl	KpnI-HF
Add to 50 µl	H₂O

Temp.: 37°C
Incubation time: 1.5h

0.7% agarose gel, upper bands cut out, digest worked.

Roth ladder - Cas9-KRAB (4826bp) - pIG6000 (upper band 2721bp, insert 1064bp)

Gel extraction of digested fragments

Cas9: 16.2ng/µl
dIG6000: 17.5ng/µl
frozen at -20°C

25.07.13

Ligation of digested Cas9-PCR product and dIG6000

Calculation:

Cas9-PCR = backbone (4826bp)
dIG6000 = insert (2721bp)

(30ng backbone/bp backbone) x bp insert x 3 = ng insert
30ng Cas9-PCR/4826 x 2721 x 3 = 50.7ng dIG6000

amount	substance
30ng = 1.85µl	Cas9-PCR (16.2ng/µl)
50.7ng = 2.89µl	dIG6000 (17.5ng/µl)
2µl	T4 ligase buffer (Fermentas)
1µl	T4 Ligase (Fermentas)
Add to 10 µl	H₂O

30min at 22°C

Transformation

2.5µl of ligation used. >1h on 37°C shaker.
plate 50µl, centrifuge & discard supernatant, plate rest.
2 a.m.: colonies picked for mini prepping.

26.07.13

Miniprep of colonies 1-4

with Roche kit.

Mini	1	2	3	4
concentration in ng/µl	77.7	13.9	65	45

Testdigest of Minis with SacII and KpnI

µl	type
about 200 ng	DNA
1	NEB-Buffer Cut Smart
0.25	SacII (undiluted)
0.5	KpnI-HF
Add to 10 µl	H₂O

Temp.: 37°C
Incubation time: 1-2h
expected fragments:

4826bp for Cas9-KRAB-bgh
2722bp for pSB1C3-CMV (dIG6000)

Roth marker, mini1, 2, 3, 4, pIG6000
Cas9-KRAB (4826bp) pIG6000 (upper band 2721bp, insert 1064bp)
in mini2 slight Cas9 band is visible (marked by star).

Concentration too low to send for sequencing, try PCR with truncation primers instead. If Cas9 is there, PCR should work.

27.07.13

Test-PCR on Mini2 for Truncation 2

fw: oIG9032 rev: oIG9033
fragment size: 7250bp

Annealing: 63°C
Extension: 4min
25 cycles

Mini preps of ligation colonies 5-7 and 2&4 again to yield higher concentrations

Mini	2	4	5	6	7
concentration in ng/µl	193.1	181.9	230.8	171.8	215.8

Test digest of Minis with SacII and KpnI

For protocol see 26.7.13. 1µl of each Mini prep was used.

0.7% Agarose gel of PCR and Test Digest

up: Roth 1kb ladder - Test PCR1 - Test PCR2
down: Roth 1kb ladder - Mini2 - 4 - 5 - 6 - 7
4, 5 and 7 seem to be positive!

Roth 1kb ladder - Mini2 - 4 - 5 - 6 - 7
Mini 5 is not completely digested, probably because of high concentration (230ng/µl!)

Minis 5 and 7 contain Cas9-KRAB and can be used as truncation PCR templates.

29.07.13

Truncation PCRs

annealing: 64°C
elongation: Truncation 1&2 4min, Truncation 3,4 & 5 3:30min

Roth 1kb ladder - Truncation1 - 2 - 3 - 4 - 5

Gibson of truncated Cas9 plasmids

Trafo of Gibson

30.07.13

Truncation 3 and 4 yielded 10-15 colonies each. No colonies on other plates. 8 colonies from each plate were picked and streaked out for mini preps.

Truncation PCR 1, 2 and 5 repeated as on 29.7.

Roth 1kb ladder - Truncation PCR 1 - 1 - 2 - 2

Roth 1kb ladder - Truncation PCR 5 - 5 - BbsI digested pIG3010

BbsI digest of RNA plasmid (from Hormon group)

Roth 1kb ladder - Truncation PCR 5 - 5 - BbsI digested pIG3010

31.07.13

Mini preps and test digest of truncation 3 and 4

Minis: >200ng/µl, 1µl was digested with EcoRI and SpeI (both HF) for 2h at 37°C.

Roth 1kb ladder - MiniT3 1-2-3-4-5-6-7-8- -pIG9100
Roth 1kb ladder - MiniT4 1-2-3-4-5-6-7-8- - gelex PCR1-2-5- Roth ladder

Gel Ex of truncation PCR 1, 2 and 5

9-15ng/µl, test size on gel.

gelex PCR1-2-5- Roth ladder

Gibson of truncation 1, 2 and 5

5µl of gel extracted PCR product were added to aliquoted Gibson master mix, 1h 50°C. 300µl were plated on chloramphenicol plates.

Testdigest

as the sequenzing of T3 showed unclear results we did minipreps of 4 more colonies from the gibson plate and digested them with EcoRI and SpeI to yield another positive testdigest that could be sequenzed.

RNA-Plasmid

Gel ex of BbsI digested plasmid

Oligo annealing of EGFP oligos

Ligation with EmxI and EGFP crRNA target oligos

August

06.08.13

Seeding cells for transfection

120,000cells/ml were seeded in six well plates (3ml per well)

Sequencing of RNA Plasmids

Both EGFP and EMX1 were inserted correctly (enter clone number)

07.08.13

Inoculate Midis for T1, 2, 5, pIG9100(Cas9), pIG3010(EMX1, EGFP)

100ml LB + 100µl Chloramphenicol. For T2 four additional minis were inoculated for midi and sent for overnight sequencing.

Truncation 4

Due to 200 missing base pairs more colonies could be screen from T4 plate: 9 clones streaked out for mini prepping (edit 8.8 plates put in 4°C bacterial fridge, prep when suitable).

08.08.13

Midipreps of plasmids

All plasmids were prepped because sequencing was delayed. Concentrations: ?

Transfection

Medium change was performed 7 hours before transfection.

3µg DNA were transfected per well (six well plate). Of truncation 2 all midis were transfected because sequencing results were still missing (pIG9102-3, -1, -5, -7 and -8 transfected). Transfection scheme?

ELISA

96 well plate (flat, high-binding) was coated with streptavidin (100µl per well, 4µg/ml working solution), sealed and incubated over night at 4°C.

10xTBS was prepared (50mM Tris, 125mM NaCl, pH 7.5)

09.08.13

Cell lysis and ELISA (Fenja and Philipp)

did not work; repeat everything.

12.08.13

Cell Seeding

aprox. 65,000 cells/ml seeded in 6 well plates.

Sequencing Results for Truncation 2

T2.3 is positive

13.08.13

Transfection

Natalie transfected the truncations (two 6-wells)

uniBAss II

Coating plate with streptavidin

14.08.13

Cell lysis

With dilution buffer (500µl per 6-well) and sonification (10min)

uniBAss II

Triplicates of the probes were run on the plate but the ELISA did not work. It´s hard to say why we could not detect bound dCas9. Secondary antibody broken? Try again..

15.08.13

Cell Seeding

approx. 65,000 cells/ml seeded in 6 well plates.

16.08.13

Transfection

PIF-GFP served as a transfection control.

17.08.13

uniBAss III

No dCas9 in pSB1C3 detectable. Test if dCas is expressed: Western Blot with remaining cell lysate against HA-tag.

Results of uniBAss ELISA experiment

18.08.13

Cell lysis and Blot

Done at AG Warscheid. anti-HA antibody overnight.

19.08.13

Detection of blot

Anti-mouse antibody (xh), washing steps, detection with ECL. illumination for 1000sec, only unspecific bands. Repeat western Blot: transfection, lysis, SDS PAGE, blot.

Cell seeding and transfection

HEK-293H from Adrian were seeded and transfected 5h afterwards.

20.08.13

Transfection did not work, the cells died because they did not tolerate the transfection only a few hours after seeding. We therefore seeded new cells.

21.08.13

Transfection

Transfection was performed by Lisa and we let cells grow for 48h! Medium change after 5h.

22.08.13

SDS gels

For the westernblot tomorrow SDS gels were poured with the invitrogen system.

23.08.13

Cell Lysis

Cell lysis was performed with modified RIPA buffer (200µl per 6-well), incubated on ice 10min, scraped off with pipet tip, in eppi, on ice for 5-10min, centrifuge 5min, 10000xg.
boil 150µl lysate with 50µl 4x sample buffer (5min, 95°C).

SDS PAGE

The probes were loaded onto the gel.

Western Blot

Semidry western blot was performed and after blocking anti-HA mouse 1:2000 (AG Weber) in TBS with BSA was applied over night.

24.08.13

Detection

Secondary antibody (1.5µl anti-mouse in 25ml TBS), wash for 2h..

Still no dCas9 in pSB1C3!

29.08.13

Truncation PCRs with standardized Cas9 (CMV-HA-NLS-Cas9-bGH)

All PCRs were done as on 29.07.13 with 4min elongation time and 64 °C annealing temperature. All PCRs worked.

Truncation PCRs T1, T2, T3, T4, T5

Gel extraction of PCR products

with Roche kit, eluted in 25?µl H₂O. Concentrations between 10-40ng/µl.

Gibson and transformation of standardized truncations

5 µl of PCR product (gelex) were mixed with Gibson mastermix, 1h 50°C, 3min RT, 3min on ice, trafo with 5 µl. Everything plated.

30.08.13

Picking colonies and minipreps

colonies for all truncations were picked and inoculated for mini-prepping in liquid cultures. Mini preps were not successful because cultures were too thin. more colonies were streaked out on agar plates to grow over night.

31.08.13

Mini Preps and test digest of standardized truncations

four colonies of each T1, T2, T3, T4, T5 were preped with Roche kit and eluted in 50 µl H₂O.

Mini preps were test digested with XbaI and PstI-HF in Cut-Smart buffer (10 µl volume, 2h, 37 °C) and separated on a 1% agarose gel.

31.08.13 test digest. Log2 marker, T1-1,-2,-3,-4, T2-1, etc.

Seeding Cells

2/3 of one 10cm plate were seeded into two 6well plates.

Midi preps of standarized truncations

Midi preps of pIG9200-9205 (chloramphenicol) + pIGCas-mCherry (ampicillin) were inoculated in 100 ml LB+100 µl antibiotic (Mini T1-1, T2-1, T3-1, T4-3, T5-1).

September

01.09.13

Midi preps of standardized truncations

Plasmids were midi prepped with Promega vacuum "Sau", 6ml buffer amounts used, columns were not dried from ethanol before eluting. Some columns were clogged and had to be scraped free with steril pipet tips. Plasmids were eluted in 300 µl nuclease free H₂O. Where possible Midis were diluted to 400ng/µl.

Plasmid	pIG9200	pIG9201	pIG9202	pIG9203	pIG9204	pIG9205	pIGCas9-mCherry
concentration in ng/µl	400	400	400	400	400	240	400

Transfection of standardized truncations

All midi-prepped plasmids were transfected (6well protocol, 3µg total DNA) with pIG9000, PIF-GFP and pIG2004 as controls. This transfection will be used for western blotting to see if the standardized Cas9 is expressed in pSB1C3.

Transfection scheme for uniBAss ELISA experiment

02.09.13

Sequencing

Midi preps of standarized truncations 1-5 were sent for sequencing with CMV forward primer @ GATC or oIG6018.

Cells seeded for ELISA

65,000 cells/well were seeded in 6-well plates as transfection will only be on wednesday (04.09.).

03.09.13

Sequencing results and cell harvesting

All sequencing results were useless (sequence length 0nt). Therefore no western blot was done today but cell pellets were collected and frozen. wells transfected with fluorescent proteins were photographed (link pics..). For harvesting cells were washed with cold PBS and then rinsed from well bottom with 500 µl cold PBS and collected in 1.5ml Eppis. Samples were centrifuged 5min at full speed (21000xg), supernatant was decanted and cell pellets were frozen at -20°C.

pIG9200 and mini T1-1 (pIG9201) were sent for sequencing again with CMV-F and BGH-R (both @ GATC).

04.09.13

Western blot

still no sequencing results. pellets blotted anyway. sample buffer, sonifyer, SDS PAGE, semidry blot (not enough transfer buffer?? gels dried out), block in TBST+milk 1h30, anti-HA-mouse 1:2500 in TBST+milk over night.

GATC is repeating seuquencing of pIG9200 and pIG9201 with oIG6017.

retrafo and new minis (in 1.5ml eppis) of T1-5? Natalie.

Transfection of pIG9200 truncations with EMX1-RNA Plasmid

Transfection scheme for uniBAss ELISA experiment

05-07.09-13

Sequencing results

sequencing did not work because no CMV promoter in construct! finally sequenced with oIG6017: result: SV40(!)-NLS-Cas-BGH, no CMV promoter and no HA-tag! Therefore all our truncation constructs are useless. We have to wait for the standardized CMV-HA-NLS-Cas9-BGH construct.

09.09.13

Cloning of CMV-HA-NLS-Cas9-BGH

We received HA-NLS-Cas9-BGH from standardization group and have to ligate it with the CMV promoter.

Mini prepping and test digest

some colonies were prepped and test-digested with NgoMIV or NotI.(Natalie)
Mini1 (407ng/µl) was used for digest.

Digestion with EcoRI/XbaI and EcoRI/SpeI

HA-NLS-Cas9-BGH is cut open with EcoRI-HF and XbaI, the CMV promoter (pIG0019, 5ng/µl) is cut out with EcoRI-HF and SpeI-HF to then be ligated into the opened Cas9-backbone.

µl	type
1-2µg (4µl Cas9, 20µl CMV)	DNA
5	Cut-Smart NEB buffer
1	EcoRI-HF
1	XbaI / SpeI-HF
Add to 50µl	H₂O

Temp.: 37°C
Incubation time: 2h

Roth 1kb marker - HA-NLS-Cas9-BGH - CMV
Cas9 backbone has correct size (6466bp), CMV insert (603bp) maybe lies in bromphenol blue band? Cut out and gelex anyway.

Gelex

both bands were gelexed with Roche Kit and eluted in 20µl H₂O.

HA-NLS-Cas9-BGH = 38,9ng/µl
CMV = 5ng/µl

Ligation

50ng of Cas9 backbone were ligated with 15ng of CMV insert. Two ligations were set up, with our CMV-digest (N+L) and one of the standardization group (St.)

µl	type
1.5	Cas9 backbone
3	CMV insert (N+L or St.)
2	T4 buffer
1	T4 Ligase (Fermentas?)
12.5	H₂O

Room temperature
Incubation time: 30min

Trafo

4µl were used for trafo of each ligation

10.09.13

Minis

four colonies of each ligation were picked and inoculated in 1.5ml Eppis with 1ml LB+ 1µl Chloramphenicol at 37°C, 700rpm. Eppis were opened frequently to ensure O₂ supply.

11/12.09.13

Sequencing results

no CMV promoter...

12-18.09.13

New cloning strategy with new CMV promoter

Ligations done again to produce SV40-HA-NLS-dCas9-NLS-BGH (pIG0063) and CMV-HA-NLS-dCas9-NLS-BGH (pIG0062). Both used as templates for truncation PCRs. Only CMV constructs shall be tested at first, as we expect higher expression (and thus more easily detectable binding levels in uniBAss) here.

19-20.09.13

Sequencing of truncation minis

Minis for each truncation with CMV promoter were sent for sequencing, had to be repeated for T1,2,4 and 5 due to frameshifts/extra primer insertions etc.. Wait for results on Monday, but inoculate midis anyway on Sunday.

22.09.13

Seeding cells

Four 6-well plates were seeded with 130,000cells/ml=260,000cells/well.

Midis inoculated

Midis of T1-T5 were inoculated (except for T3, already done by Michi and Nadine). Gabi :)

23.09.13

Midis and transfection of CMV-T1-5

Finally sequencing results were correct (T4 was repeated:check tomorrow), inoculated midis were prepped with Promega kit (double buffer amounts) and eluted in 600µl nuclease free H₂O.

Transfection was performed as on plan in 6-well plates. Additionally all standardized constructs (CMV and SV40) and their non-standardized pX334a-versions were transfected to be compared on uniBAss. The Assay will be performed 48h after transfection. change of media required? check in the morning!

Transfection scheme for uniBAss ELISA experiment

24.09.13

No medium change of the cells transfected the day before was performed. SDS-Gel for the westernblot which will be performed tomorrow poured. The ELISA plate for uniBAss is coated with streptadivin.

25.09.13

uniBAss ELISA

The HEK-293T cells were lysed about 42h after transfection. The uniBAss ELISA was performed according to the protocol. In parallel a westernblot was performed with 2/5 of the lysate of each well to ensure dCas9 expression.

25.09.13

Westernblot of uniBAss probes

The westernblot of yesterday was analyzed. Due to problems with resolving the protein pellet we had suboptimal results in the blot.

Therefore we want to repeat the hole experiment. As two days before we transfected HEK-293T cells in 6-wells: transfection scheme. This time we made biological duplicates for the standardised constructs. (together six 6-wells)

26.09.13

Medium of the six 6 wells was exchanged 12h after transfection.

27.09.13

Westernblot of 2. uniBAss probes

As an expression control we wanted to perform the westernbot of the transfected cells this time before we to the uniBAss ELISA. So we collected the cells in 500µl diluent buffer and took 170µl for western blotting. The 170µl cell suspension was centrifuged for 5min at 10,000xg, the supernatant decanted and the pellet resuspended in 100µl SDS-sample buffer. Then the suspension was sonified for a total of 35min. The probes were cooked for 15min and SDS-page was performed, followed by a semidry westernblot. After blocking, the primary antibody (mouse-anti-HA) was applied over night.

28.09.13

Development of the westernblot. After washing and applying the secondary antibody we developed the membranes.

We could detect most of our constructs and had very nice bands. So we want to perform the uniBAss with all our probes tomorrow, therefore we coated an ELISA plate with streptavidin.

29.09.13

uniBAss ELISA V

To perform the uniBAss we had to unfreeze our probes from the -80°C freezer. Then we sonified them and proceeded with our usual uniBAss-protocol. Except for the constructs containing a CAG promoter all constructs are standardized and in pSB1C3. CMV-GFP serves as a negative control as it contains no dCas9 (and thus no HA-tag), CMV-dCas9 neg contains no RNAimer plasmid and also should not be able to bind the EMX1 oligo. As a control for specificity of the binding we coated one well for each construct without any oligo and an additional well with a VEGF oligo that is not complementary to the EMX1 target site on the RNAimer that was co-transfected with all dCas9-constructs.

We received lower ABTS readouts for our dCas9 fusion constructs than for the dCas9 alone. But is due to significant weaker expression of the fusion-constructs. Therefore we normalized the values of the ABTS readout in the ELISA to the dCas9 amount with the help of the westernblot of the respective contructs. We substracted the no oligo values and then set the dCas9 alone to 100% expression.For the dCas9-VP16 construct we received a value of 25,6% expression after analysis with imageJ. For dCas9-KRAB 5,4% and for dCas9-G9a 53,7%. Errorbars show the standard deviation of two technical replicates.

uniBAss ELISA results 29.09.13.

Again only the non-standardized constructs show an ABTS signal, meaning that no dCas9 binding is detected in our standardized pSB1C3 constructs. This is probably due to the low expression of CMV-dCas9 and SV40-dCas9 we observed in the western blot which might not be sufficient to be detected with uniBAss. For the other oligo control we see strange off target effects that are probably due to a technical mistake. Maybe our BSA batch is not working properly as we get too high values for unspecific binding. The results show non the less that there is no binding detected for negative controls lacking dCas9 or the RNAimer plasmid.

After evaluating the results of the assay we desided to repeat the experiment one more time. Next time we will try to use more cell lysate to get higher amounts of dCas9 protein so that effects for the dCas9 in pSB1C3 can be seen in uniBAss. Therefore four 6-well plates HEK-293T cells are seeded which will be transfected tomorrow. We will try the following changes in our uniBAss protocol:

Transfection in duplicates to gain more volume of lysate
take up cells in 100-200µl dilution buffer per 6-well to obtain higher dCas9 concentration in lysates
sonify cells for 10min
centrifuge lysate before applying it to the 96-well ELISA plate to get rid of cell debris
increase oligo concentration when coating the wells
try a different off-target oligo from AG Weber

30.09.13

Transfection

This time we transfected only the standardized constructs but in biological duplicate to have enough cell lysate for uniBAss. Ilona did the transfection of the four 6-well plates.

October

01.10.13

New 10xTBS was made and the uniBAss ELISA plate was coated with streptavidin.

02.10.13

last but not least uniBAss

Today we performed the last trial to get results with uniBAss with the standardized constructs before the Jamboree in Lyon.

The ELISA plate well were blocked and coated with oligos (EMX1, other oligo from AG Weber, no oligo). Then wells were blocked again with blocking buffer containing new BSA (Sigma). Cells were scraped off in 160µl dilution buffer (also with new BSA) per 6-well, sonified for 10min at 4°C and centrifuged 5min at 500xg. 100µl of lysate was applied to each well and incubated for more than 1h. Afterwards the standard protocol was followed.

All efforts taken to upconcentrate the amount of dCas9 in pSB1C3 were not enough to see an effect in uniBAss. Due to a lack of time we will not repeat the uniBAss again.

06.10.13

Seeding of cells for functional test of all truncations

2 24-well plates were seeded with 65,000 cells per well.

07.10.13

Transfection

One plate was transfected with a reporter plasmid containing SEAP under the control of a CMVmin promoter, differnently truncated dCas9-VP16 constructs and two RNA plasmids (activation via VP16); the other with a reporter plasmid containing SEAP under the control of a SV40 promoter, differnently truncated dCas9 constructs and two RNA plasmids (repression via CRISPRi).

40 µl Opti-MEM + 0.75 µg of the DNA of interest were mixed in a 1.5 ml Eppi.
Addition of 2.25 µl PEI-solution, vortexing for 10 s and incubation for at least 15 min at RT.
Solution was spread drop-wise to the cells in the dish

Ratio of DNA amount (mass):
reporter plasmid (SEAP) : effector plasmid (Cas9) : RNA plasmid
1 : 4 : 4
Additionally a plasmid coding for Renilla luciferase was cotransfected (5 % of DNA amount)

08.10.13

Medium change

Medium was changed after 12 h.

09.10.13

Medium removal

Supernatant was collected for SEAP measurement 36 h after transfection for repression and 46 h after transfection for activation.
Cells of repression were frozen at - 80 °C for later on Renilla measurement.

SEAP measurement of repression

Collected supernatant and fresh cell culture medium was heated at 65 °C for 30 min, then centrifuged at 1250 g for 1 min.
Supernatant was diluted in cell culture medium 1:5 and 1:10.
80 µl of (diluted) supernatant was applied to 100 µl of SEAP buffer.
After addition of 20 µl pNPP (substrate of SEAP) the absorbance of the mix was measured every minute for 2 h at 405 nm.

SEAP measurement of activation

Collected supernatant and fresh cell culture medium was heated at 65 °C for 30 min.
80 µl of supernatant was applied to 100 µl of SEAP buffer.
After addition of 20 µl pNPP (substrate of SEAP) the absorbance of the mix was measured every minute for 2 h at 405 nm.

Cell lysis for lyciferase measurement

250 µl of lysis buffer (containing Tris-HCl, EGTA, MgSO₄, DTT and protease inhibitor) were applied to the (thawn) cells of each well.
Incubation on ice for at least 10 min.
Centrifugation at 2,200 g for 15 min.

Luciferase luminescence measurement

80 µl of supernatant were pipetted in a white 96 well plate.
Measurement of luminescence (every 2 min for 15 min) immediately after addition of 20 µl Renilla substrate in PBS.

Results of activation via VP16
Truncation clearly activated SEAP expression, but afterwards sequencing revealed that the truncation did not work. So T4 is actually the same as the positive control.

Results of repression via CRISPRi
After normalization to Renilla expression the positive and the negative controls had almost the same values. So there can not be drawn a validated conclusion from this experiment. Nevertheless it is conspicuous that the SEAP level of truncation 4 is clearly below the ones of 2, 3 and 5.

10.10.13

Digestion of uniCAS Truncation 4 with EcoRI and AgeI. Simultaneous digestion of G9a, Krab, KrabKrab, VP16, VP32, VP64 in RFC25 standard with NgoMIV and SpeI. Additionally, digestion of the BgH terminator in RFC10 with XbaI and EcoRI. Subsequent ligation of three fragments each. uniCas Truncation 4 and BgH terminator fragments were the same for all plasmids, whereby only the effector domains were exchanged among the constructs to-be cloned.

14.10.13

Striking out of four colonies per attempt: uniCAS T4-VP16, uniCAS T4-VP32, uniCAS T4-VP64, uniCAS T4-Krab, uniCAS T4-KrabKrab and uniCAS T4-G9a.

15.10.13

Miniprep of clones. Testdigest with NotI. All constructs have shown positive digest results, except for uniCAS T4-VP32.

Roth 1kb marker, T4 (neg. control), T4-VP16, T4-VP64, T4-VP64, T4-Krab, T4-KrabKrab, T4-G9a, Roth 1kb marker

After NotI digestion, a ~ 600 bp band, indicating the CMV promoter became recognizable for all obtained vectors. Moreover, according to the size of the upper band, it was also obvious to detect size differences among constructs such as VP16 and VP64.

16.10.13

Seeding of cells for functional test of truncation 4

2 24-well plates were seeded with 65,000 cells per well.

17.10.13

Transfection

One plate was transfected with a reporter plasmid containing SEAP under the control of a CMVmin promoter, truncated dCas9-VP16 / VP64 constructs as well as two RNA plasmids (activation); the other with a reporter plasmid containing SEAP under the control of a CMV promoter, truncated dCas9-KRAB2 / G9a constructs and a RNA plasmid containing two crRNAs (repression).

40 µl Opti-MEM + 0.75 µg of the DNA of interest were mixed in a 1.5 ml Eppi.
Addition of 2.25 µl PEI-solution, vortexing for 10 s and incubation for at least 15 min at RT.
Solution was spread drop-wise to the cells in the dish

Ratio of DNA amount (mass):
reporter plasmid (SEAP) : effector plasmid (Cas9) : RNA plasmid
1 : 4 : 4
Additionally a plasmid coding for Renilla luciferase was cotransfected (5 % of DNA amount)

18.10.13

Medium change

Medium was changed after 14 h.

19.10.13

Medium removal

Supernatant was collected for SEAP measurement 36 h after transfection for repression and 46 h after transfection for activation.
Cells of repression were frozen at - 80 °C for later on Renilla measurement.

20.10.13

SEAP Assay

Results of SEAP activation via uniCAS truncation No. 4 with VP16 and VP64 effectors. An activation by the truncated constructs could not be observed - as obvious by comparing the positive control (left) with any of the vectors.

Results of SEAP repression via uniCAS truncation No. 4 with G9a and Krab effectors. Strongfold downregulation could be observed in most cases. However, as off-target repression only occurs, it can be assumed that the repressive effect does not emerge from the domains or locus-specific binding.

@@ Line 42: / Line 42: @@
 </p>
-<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/lab_effector"> Effector </a></p>
-<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/induction"> Induction </a> </p>
 <p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/crrna"> Targeting </a></p>
+<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/lab_effector"> Effectors </a></p>
+<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/induction"> Effector Control </a> </p>
+<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/modeling"> Modeling </a></p>
 <p class="first_order"><a class="active" href="https://2013.igem.org/Team:Freiburg/Notebook/method"> uniBAss </a></p>
@@ Line 52: / Line 53: @@
 <p class="third_order"> <a href="#august"> August </a> </p>
 <p class="third_order"> <a href="#september"> September </a> </p>
+<p class="third_order"> <a href="#october"> October </a> </p>
-<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/modeling"> Modeling </a></p>
+<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/standardisation"> Standardization </a></p>
-<p class="first_order"><a href="https://2013.igem.org/Team:Freiburg/Notebook/standardisation"> Standardisation </a></p>
+<p class="first_order" > <a id="link" href="https://2013.igem.org/Team:Freiburg/protocols"> Material and Methods </a> </p>
-<p class="first_order"> <a id="link" href="https://2013.igem.org/Team:Freiburg/protocols"> Protocols </a> </p>
@@ Line 72: / Line 73: @@
 </div>
+<!--
 <p id="h3">
   Labbook Development of the uniBAss
 </p>
+-->
-<div id="May">
+<div id="may">
 <p id="h2">
 May
@@ Line 85: / Line 85: @@
 </div>
+<div id="tag">
+<h2> 15.05.13 </h2>
 <h3>  Digest with BbsI </h3>
    <div id="floatleft">
@@ Line 106: / Line 108: @@
 		  <tr>
-		    	<td> Add to 50 &micro;l </td>
+		    	<td> Add to 50&micro;l </td>
 		    	<td> H<sub>2</sub>O </td>
 		  </tr>
@@ Line 112: / Line 114: @@
    </div>
-   <p>pX334a was digested for 2h at 37°C using BbsI for subsequent target insertion
+   <p> pX334a was digested for 2h at 37&deg;C using BbsI for subsequent target insertion.
    </p>
 <h3> Gel extraction of the digested pX334a </h3>
-   <p>Bands were cut out and extracted with Roche high pure PCR product purification kit. Eluation in 20 &micro;l H<sub>2</sub>O, before centrifugation: incubated 10min at room temp. Eluted liquid put on column again, incubated for 10 min and centrifuged.
+   <p> Bands were cut out and extracted with Roche high pure PCR product purification kit. Eluation in 20&micro;l H<sub>2</sub>O, before centrifugation: incubated 10min at room temp. Eluted liquid put on column again, incubated for 10 min and centrifuged.
-concentrations: less than 16.5 ng/ul.
+concentrations: less than 16.5ng/&micro;l.
    </p>
-<h3>  Ligation of digested pX334a with annealed oIG2007-oIG2008  (EMX1 locus) </h3>
+<h3>  Ligation of digested pX334a with annealed oIG9007-oIG9008  (EMX1 locus) </h3>
    <div id="floatleft">
      	<table class="tabelle">
@@ Line 138: / Line 140: @@
 		    	<td> 0.5&micro;l </td>
 		    	<td> T4 ligase </td>
 		  </tr>
 	  </table>
    </div>
-  <p>Five different ligation mixes (dilution row of insert, 1x, 10x 100x ,500x, 1000x diluted insert) + the negative control with water instead of oligo were incubated for 1h at 22°C. This resulted in pIG9000.
+  <p> Five different ligation mixes (dilution row of insert, 1x, 10x 100x ,500x, 1000x diluted insert) + the negative control with water instead of oligo were incubated for 1h at 22&deg;C. This resulted in pIG9000.
    </p>
-<h3>  Transformation of Top10 E.coli with the pX334a containing the EMX1 locus (pIG9000) </h3>
+<h3>  Transformation of Top10 <i>E. coli</i> with the pX334a containing the EMX1 locus (pIG9000) </h3>
-   <div id="floatleft">
-    	<table class="tabelle">
-<p> The 6 different samples were transformed following the protocol and were thus given on an agar plate with Ampicilline and incubated over night </p>
+<p> The 6 different samples were transformed following the protocol and were thus given on an agar plate with Ampicilline and incubated over night. </p>
+</div>
-  <h2> 16.  May </h2>
+<div id="tag">
+  <h2> 16.05.13 </h2>
 	<h3> Picking colonies and streakout </h3>
-<p> The negative control showed five colonies whereas the plate with 1x duluted insert had 12 colonies, 10x had 17 colonies, 100x had 17 colonies, 500 had 10 colonies, 1000x hat 18 colonies. From each of the two plates with the most colonies were 8 colonies picked. 16ten streakouts were performed on AMP agar plates and incubated over night at 37°C  </p>
+<p> The negative control showed five colonies whereas the plate with 1x duluted insert had 12 colonies, 10x had 17 colonies, 100x had 17 colonies, 500 had 10 colonies, 1000x hat 18 colonies. From each of the two plates with the most colonies were 8 colonies picked. 16ten streakouts were performed on AMP agar plates and incubated over night at 37&deg;C.  </p>
+</div>
-  <h2> 17.  May </h2>
+<div id="tag">
+  <h2> 17.05.13 </h2>
 	<h3> Miniprep and testdigest </h3>
-<p> The miniprep was performed as stated in the protocol. Afterwards a testdigest was performed </p>
+<p> The miniprep was performed as stated in the protocol. Afterwards a testdigest was performed. </p>
 <h3>  Testdigest of 16. possible pIG9000 colonies, mastermix contained </h3>
@@ Line 191: / Line 194: @@
 		    	<td> H2O </td>
 		  </tr>
 	  </table>
    </div>
+<p> After 2h at 37&deg;C the samples were applied on an agarose gel (1% Agar, 0.5 TAE to 50 ml) to visualize band 3 ul gel red was used. The gel displayed that some colonies showed no additional band and therefore are likely to have the insert included. Those positive minipreps were send to sequencing at GATC.
+</p>
+<p> The sequencing results validated that the insert was successfully cloned into pX334a and therefore pIG9000 was ready for the testing on the ELISA.
+</p>
-<p> after 2h at 37°C the samples were applied on an agarose gel (1% Agar, 0.5 TAE to 50 ml) to visualize band 3 ul gel red was used. The gel displayed that some colonies showed no additional band and therefore are likely to have the insert included. Those positive minipreps were send to sequencing at GATC</p>
+</div>
-<p> The sequencing results validated that the insert was successfully cloned into pX334a and therefore pIG9000 was ready for the testing on the ELISA. </p>
-  <h2> 18.  May </h2>
+<div id="tag">
-	<h3> Oligoannealing and transformation of E.coli with pIG9000 with the aim the perform a midi prep </h3>
+  <h2> 18.05.13 </h2>
+	<h3> Oligoannealing and transformation of <i>E. coli</i> with pIG9000 with the aim the perform a midi prep </h3>
-<p> The oligoannealing with the biotinylated oligonucleotides oIG9000, oIG9001 and oIG9002 was performed at 95°C for 5 minutes, afterwards the heating block was turned off. The transformation was performed following the protocol. The transformed cells were given into 150ml LB-media containing AMP and were incubated overnight at  37°C </p>
+<p> The oligoannealing with the biotinylated oligonucleotides oIG9000, oIG9001 and oIG9002 was performed at 95&deg;C for 5 minutes, afterwards the heating block was turned off. The transformation was performed following the protocol. The transformed cells were given into 150ml LB-media containing AMP and were incubated overnight at 37&deg;C.</p>
+</div>
-  <h2> 19.  May </h2>
+<div id="tag">
+  <h2> 19.05.13 </h2>
 	<h3> Performing a midiprep </h3>
-<p> A midiprep of the E.coli containing pIG9000 was performed following the protocol. Result: 2487ng/ul in a volume of 200ul. </p>
+<p> A midiprep of the <i>E. coli</i> containing pIG9000 was performed following the protocol. Result: 2487ng/&micro;l in a volume of 200&micro;l. </p>
+</div>
+<div id="tag">
-  <h2> 20.  May </h2>
+  <h2> 20.05.13 </h2>
 	<h3> Seeding cells for transfection </h3>
-<p> HEK293T cells were seeded at a density of 250.000 cells/ml. The conservation culture contained 60.000 cells/ml. </p>
+<p> HEK-293T cells were seeded at a density of 250,000 cells/ml. The conservation culture contained 60,000 cells/ml. </p>
-<p> Human embryonic kidney cells (HEK-293T) were cultivated in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10 % Fetal Calf Serum (FCS) and 1 % penicillin / streptomycin solution (DMEM complete) and incubated in a moisturized atmosphere containing 5 % CO2. Cells were detached with 2.4 ml Trypsin-EDTA solution, transferred into 7 ml fresh medium and centrifuged for 3 min at 900 x g. The supernatant was removed and the pelleted cells were resuspended in 5 - 7 ml medium. Cell numbers were determined by transferring 100 μl cell solution to 10 ml of Casyton Buffer and counted in an Innovatis Casy Cell counter (Casy-Technology, Reutlingen, Germany, model TT). For maintaining cultures, HEK-293T cells were cultivated in petridishes with a starting concentration of 0.6 or 1.2*106 cells in 10 ml medium and incubated as described before.</p>
+<p> Human embryonic kidney cells (HEK-293T) were cultivated in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10 % Fetal Calf Serum (FCS) and 1 % penicillin / streptomycin solution (DMEM complete) and incubated in a moisturized atmosphere containing 5 % CO2. Cells were detached with 2.4 ml Trypsin-EDTA solution, transferred into 7 ml fresh medium and centrifuged for 3 min at 900 x g. The supernatant was removed and the pelleted cells were resuspended in 5 - 7 ml medium. Cell numbers were determined by transferring 100&micro;l cell solution to 10 ml of Casyton Buffer and counted in an Innovatis Casy Cell counter (Casy-Technology, Reutlingen, Germany, model TT). For maintaining cultures, HEK-293T cells were cultivated in petridishes with a starting concentration of 0.6 or 1.2*106 cells in 10 ml medium and incubated as described before.</p>
-  <h2> 21.  May </h2>
+</div>
+<div id="tag">
+  <h2> 21.05.13 </h2>
          <h3> Contamination & seeding cells </h3>
 <p> Contamination occured therefore the cells had to be seeded again following the protocol.</p>
+</div>
-  <h2> 23.  May </h2>
+<div id="tag">
+  <h2> 23.05.13 </h2>
          <h3> PEI Transfection and preparation of uniBAss experiment </h3>
-<p> Seeded cells were transfected with pIG9000 following the protocol
+<p> Seeded cells were transfected with pIG9000 following the protocol. <br>
-Cells were transfected using the PEI transfection method with the following concentrations: Typically for a 200 µl transfection mix, 1.5 µg of DNA and 5 µl PEI (Polysciences, Inc., PA, cat. no. 23966) were filled up with OptiMEM (Invitrogen GmbH, Darmstadt, Germany cat. no. 11058-021) to 100 µl. Afterwards, the 100 µl PEI solution was added to the 100 µl DNA solution, vortexed and incubated at RT for 15 to 30 min. Afterwards 200 µl of the PEI / DNA transfection mix was added drop-wise to each 1 ml culture medium containing cells in well plates and incubated at 37 °C, 5 % CO2. After 5 h, the medium was exchanged , Dulbecco's modified Eagle's medium (DMEM), supplemented with 10 % Fetal Calf Serum (FCS) and 1 % penicillin / streptomycin solution (DMEM complete) </p>
+Cells were transfected using the PEI transfection method with the following concentrations: Typically for a 200&micro;l transfection mix, 1.5&micro;g of DNA and 5&micro;l PEI (Polysciences, Inc., PA, cat. no. 23966) were filled up with OptiMEM (Invitrogen GmbH, Darmstadt, Germany cat. no. 11058-021) to 100&micro;l. Afterwards, the 100&micro;l PEI solution was added to the 100&micro;l DNA solution, vortexed and incubated at RT for 15 to 30 min. Afterwards 200&micro;l of the PEI / DNA transfection mix was added drop-wise to each 1 ml culture medium containing cells in well plates and incubated at 37&deg;C, 5 % CO2. After 5 h, the medium was exchanged , Dulbecco's modified Eagle's medium (DMEM), supplemented with 10 % Fetal Calf Serum (FCS) and 1 % penicillin / streptomycin solution (DMEM complete) </p>
-<p> The ELISA plates (Corning, Inc., cat. no. 3590, NY, New York) were coated with 100 µl streptavidin solution (20 µl / 10 ml in dH20 to obtain a final concentration of 4 µg / ml) and incubated overnight at 4°C. </p>
+<p> The ELISA plates (Corning, Inc., cat. no. 3590, NY, New York) were coated with 100&micro;l streptavidin solution (20&micro;l / 10 ml in dH<sub>2</sub>0 to obtain a final concentration of 4&micro;g/ml) and incubated overnight at 4&deg;C.
+</p>
+</div>
-  <h2> 24.  May </h2>
+<div id="tag">
-         <h3> uniBAss experiment to obeserve the influence of different Ion concentrations </h3>
+<div id="firstuniBAss">
+  <h2> 24.05.13 </h2>
+         <h3> uniBAss experiment to observe the influence of different Ion concentrations </h3>
+</div>
-<p> The streptavidin coated plates were washed 3 x with TBST (TBS, 2 ml / l Tween20) and 300 µl blocking buffer (1 x TBST, 1 % BSA) was added for 1 h. After 3 x washing with TBST, the biotinylated oligonucleotides (10pmol/well) were applied and incubated at RT for 1 h. Afterwards the plates were washed 3 x with TBST.
+<p> The streptavidin coated plates were washed 3 x with TBST (TBS, 2 ml / l Tween20) and 300&micro;l blocking buffer (1 x TBST, 1 % BSA) was added for 1 h. After 3 x washing with TBST, the biotinylated oligonucleotides (10pmol/well) were applied and incubated at RT for 1 h. Afterwards the plates were washed 3 x with TBST.
-To obtain the cell lysate with the Cas9 protein, the transfected HEK-293T cells (250.000 cells / ml) were resuspended in 250 µl dilution buffer (10 mM Tris, 1 % BSA, 10 mM MgCl2, 10 mM NaCl) containing EDTA free Protease inhibitor per 125.000 cells / ml and sonified for 10 min. To remove the cell fractions the lysate was centrifuged for 5 min at 500 g.
+To obtain the cell lysate with the Cas9 protein, the transfected HEK-293T cells (250,000 cells / ml) were resuspended in 250&micro;l dilution buffer (10 mM Tris, 1 % BSA, 10 mM MgCl2, 10 mM NaCl) containing EDTA free Protease inhibitor per 125,000 cells / ml and sonified for 10 min. To remove the cell fractions the lysate was centrifuged for 5 min at 500xg.
+</p>
+<p> To adjust the buffer condition a dilution row with cell lysate comprising the Cas9 were performed in round 96-well plates. The dilution buffers used were b1 (10 mM Tris, 1 % BSA, 10 mM MgCl2, 250 mM NaCl) and b2 (10 mM Tris, 1 % BSA, 100 mM MgCl2, 10 mM NaCl) respectively.
-To adjust the buffer condition a dilution row with cell lysate comprising the Cas9 were performed in round 96-well plates. The dilution buffers used were b1 (10 mM Tris, 1 % BSA, 10 mM MgCl2, 250 mM NaCl) and b2 (10 mM Tris, 1 % BSA, 100 mM MgCl2, 10 mM NaCl) respectivly.
 This resulted in the following conditions.
+</p>
    <div id="floatleft">
 	  <table class="tabelle">
@@ Line 296: / Line 313: @@
 			  <td> 0.48 </td>
 		  </tr>
 	  </table>
    </div>
@@ Line 352: / Line 368: @@
-<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br>
- Afterwards 100 µl of the diluted cell lysate was transferred to the ELISA plates. After 1 h incubation at RT the plates were washed 3 x with TBST and 100 µl anti-HA antibody solution (1000 x diluted in blocking buffer) was applied to each wells and incubated for 1 h. After 3 x washing with TBST, 100 µl anti-mouse HRP antibody (4000 x diluted in blocking buffer,) were added. After 1 h incubation, plates were washed 3 x with TBST, probed with 100 µl ELISA ABTS substrate and the absorbance was measured at 405 nm.
-For the positive controls, wells were coated with 100 µl FM protein (1.0 µg / ml) and directly with the sonificated cell lysate in the dilution buffer.
-The negative controls performed were composed of, no Antibody, no oligonucleotide at all, not the matching oligonucleotide sequence.  </p>
+<p> Afterwards 100&micro;l of the diluted cell lysate was transferred to the ELISA plates. After 1 h incubation at RT the plates were washed 3 x with TBST and 100&micro;l anti-HA antibody solution (1000 x diluted in blocking buffer) was applied to each wells and incubated for 1 h. After 3 x washing with TBST, 100&micro;l anti-mouse HRP antibody (4000 x diluted in blocking buffer,) were added. After 1 h incubation, plates were washed 3 x with TBST, probed with 100&micro;l ELISA ABTS substrate and the absorbance was measured at 405 nm.
+For the positive controls, wells were coated with 100&micro;l FM protein (1.0 µg / ml) and directly with the sonificated cell lysate in the dilution buffer.
+The negative controls performed were composed of, no Antibody, no oligonucleotide at all, not the matching oligonucleotide sequence.
+</p>
-<p> Result: XXX Figure1 </p>
+<p> in the following this protocol was always used only variations are mentioned. </p>
- <div>
+<p> Result: Figure 1 </p>
-	  <table class="Result1uniBAss">
-	    	<tr>
-	    		<td> <img class="Result1uniBAss" src="xxx"> </td>
+<div>
-	    	</tr>
+	<table class="imgtxt">
-	    	<tr>
+		<tbody><tr>
-	    		<td> Binding restrain of the Cas9 MX1 crRNA complex for bisected buffer  </td>
+			<td> <img id="bild" src="https://static.igem.org/mediawiki/2013/d/d4/Figure6Freiburg2013.PNG" width="750px"> </td>
-		    </tr>
+		</tr>
+		<tr>
+			<td> Binding restrain of the Cas9 MX1 crRNA complex for bisected buffer </td>
+		</tr>
+	</tbody></table>
+</div>
+<div>
+	<table class="imgtxt">
+		<tbody><tr>
+			<td> <img id="bild" src="https://static.igem.org/mediawiki/2013/8/87/Figure6.1Freiburg2013.PNG" width="750px"> </td>
+		</tr>
+		<tr>
+			<td> Binding restrain of the Cas9 MX1 crRNA complex for bisected buffer  </td>
+		</tr>
+	</tbody></table>
+</div>
+<p> To check if the Cas9 protein was in the cell lysate a western blot was performed </p>
+<p>For specific detection of proteins, semi-dry Western Blots were performed. The polyvinylidene fluoride membrane (PVDF) (0.45 µm, Millipore Corporation, Bedford, MA, cat. no. T831.1) was first activated in methanol then washed with dH<sub>2</sub>O and subsequently equilibrated in the transfer buffer. For Semi-dry transfer of proteins, a sandwich of Whatman paper / gel / membrane / Whatman paper (wetted with the transfer buffer) is placed directly between cathode and anode in a blotting chamber (Peqlab, Biotechnologie GmbH, Erlangen, Germany cat. no. 52-2020). The blot was performed at 450 mA for 1 h. To prevent unspecific binding of antibodies, the membrane was incubated in block
+ing solution (2 % milk in PBST) at room temperature for 1 h at shaking conditions. Afterwards, the membrane was incubated in PBST 1 % milk supplemented with the primary antibody at room temperature for 1 h. Followed by washing the membrane 3 x with PBST for 15 min, the membrane was incubated with PBST 1 % milk containing a horse radish peroxidase (HRP) conjugated secondary antibody at room temperature for 1 h. After 3 x washing with PBST for 10 - 15 min, the blot was incubated with 1 ml Western Blotting Detection Solution and detection of the chemiluminescence, emanating from the HRP-mediated conversion of the substrate was performed in an image reader .
+</p>
+</div>
+<div id="june">
+<p id="h2">
+June
+</p>
+</div>
+<div id="tag">
+<h2> 05.06.13 </h2>
+	<h3> Seeding cells for PEI transfection </h3>
+<p> The seeding of the cell was done as mentioned above.
+</p>
+</div>
+<div id="tag">
+<h2> 06.06.13 </h2>
+	<h3> PEI transfection and coating of ELISA plate </h3>
+<p> The seeding of the cell was done as mentioned above </p>
+</div>
+<div id="tag">
+<h2> 07.06.13 </h2>
+	<h3> Testing the best oligonucleotide length for Cas9/crRNA binding </h3>
+<p> The three different biotinylated and annealed oligonucleotides oIG9000 / oIG9001, oIG9002 / oIG9003 and oIG9004 / oIG9005 (10 pmol / well) were coated by incubation at RT for 1 h. The transfected HEK-293T cells (250,000 cells / ml) were harvested by sonification for 10 minutes in the dilution buffer (10 mM Tris, 1 % BSA, 125 mM NaCl, 10 mM MgCl2) and (10 mM Tris, 1 % BSA, 50 mM MgCl2, 10 mM NaCl) containing one tablet of the EDTA free Protease inhibitor cocktail per 50 ml buffer. The Buffer dilution comprising the Cas9 were performed in round 96-well plates by a 1:1.
+</p>
+ <div id="floatleft">
+	  <table class="tabelle">
+		  <tr>
+			  <th> NaCl [mM] </th>
+			  <th> MgCl2 [mM]</th>
+		  </tr>
+		  <tr>
+			  <td> 125 </td>
+			  <td> 50 </td>
+		  </tr>
+		  <tr>
+			  <td> 125 </td>
+			  <td> 25 </td>
+		  </tr>
+		  <tr>
+			  <td> 125 </td>
+			  <td> 12.5 </td>
+		  </tr>
+		  <tr>
+			  <td> 125</td>
+			  <td> 6.25 </td>
+		  </tr>
+		  <tr>
+			  <td> 125 </td>
+			  <td> 10 </td>
+		  </tr>
+		  <tr>
+			  <td> 10 </td>
+			  <td> 50 </td>
+		  </tr>
 	  </table>
    </div>
+<div>
+	<table class="imgtxt">
+		<tbody><tr>
+			<td> <img id="bild" src="https://static.igem.org/mediawiki/2013/4/4f/Figure7Freiburg2013.PNG" width="750px"> </td>
+		</tr>
+		<tr>
+			<td> <b>The results show that a total length of 40 nucleotides is not enough for the Cas9 / RNA to bind. 50 nucleotides are sufficient for binding however 60 nucleotides show the most robust binding behaviour.</b></td>
+		</tr>
+	</tbody></table>
+</div>
-<p> To check if the Cas9 protein was in the cell lysate a westernplot was performed </p>
+<div id="tag">
-<br>
+<h2> 12.06.13 </h2>
-<p>For specific detection of proteins, semi-dry Western Blots were performed. The polyvinylidene fluoride membrane (PVDF) (0.45 µm, Millipore Corporation, Bedford, MA, cat. no. T831.1) was first activated in methanol then washed with dH2O and subsequently equilibrated in the transfer buffer. For Semi-dry transfer of proteins, a sandwich of Whatman paper / gel / membrane / Whatman paper (wetted with the transfer buffer) is placed directly between cathode and anode in a blotting chamber (Peqlab, Biotechnologie GmbH, Erlangen, Germany cat. no. 52-2020). The blot was performed at 450 mA for 1 h. To prevent unspecific binding of antibodies, the membrane was incubated in block
+	<h3> Seeding cells for PEI transfection </h3>
-ing solution (2 % milk in PBST) at room temperature for 1 h at shaking conditions. Afterwards, the membrane was incubated in PBST 1 % milk supplemented with the primary antibody at room temperature for 1 h. Followed by washing the membrane 3 x with PBST for 15 min, the membrane was incubated with PBST 1 % milk containing a horse radish peroxidase (HRP) conjugated secondary antibody at room temperature for 1 h. After 3 x washing with PBST for 10 - 15 min, the blot was incubated with 1 ml Western Blotting Detection Solution and detection of the chemiluminescence, emanating from the HRP-mediated conversion of the substrate was performed in an image reader .
+<p> The seeding of the cell was done as mentioned above. </p>
+</div>
+<div id="tag">
+<h2> 13.06.13 </h2>
+	<h3> PEI transfection and coating of ELISA plate </h3>
+<p> The PEI transfection and coating of the ELISA plate was done as mentioned above. </p>
+</div>
+<div id="tag">
+<h2> 14.06.13 </h2>
+	<h3> Optimizing the buffer condition </h3>
+<p> Different concentrations of MgCl2 – 30 mM, 20 mM, 10 mM and 5 mM – and of NaCl – 150 mM, 120 mM, 90 mM and 60 mM, were varied against each other.
+</p>
+<p>
+The ELISA was performed as explained above.
+Dilution buffers containing (10 mM Tris, 1 % BSA, NaCl – 150 mM, 120 mM, 90 mM and 60 mM, MgCl2 – 30 mM, 20 mM, 10 mM and 5 mM respectivly) containing one tablet EDTA free Protease inhibitor cocktail per 50 ml were used to uptake the transfected HEK–293T cells and subsequently perform cell lysis.
 </p>
+ <div id="floatleft">
+	  <table class="tabelle">
+		  <tr>
+			  <th> NaCl [mM] </th>
+			  <th> MgCl2 [mM]</th>
+		  </tr>
+		  <tr>
+			  <td> 150 </td>
+			  <td> 30</td>
+		  </tr>
+		  <tr>
+			  <td> 150 </td>
+			  <td> 20</td>
+		  </tr>
+		  <tr>
+			  <td> 150 </td>
+			  <td> 10</td>
+		  </tr>
+		  <tr>
+			  <td> 150 </td>
+			  <td> 5</td>
+		  </tr>
+	  </table>
+  </div>
-<p id="h3">
+  <div id="floatleft">
- Labbook Cas9-Truncation
+	  <table class="tabelle">
+		  <tr>
+			  <th> NaCl [mM] </th>
+			  <th> MgCl2 [mM]</th>
+		  </tr>
+		  <tr>
+			  <td> 120 </td>
+			  <td> 30</td>
+		  </tr>
+		  <tr>
+			  <td> 120 </td>
+			  <td> 20</td>
+		  </tr>
+		  <tr>
+			  <td> 120 </td>
+			  <td> 10</td>
+		  </tr>
+		  <tr>
+			  <td> 120 </td>
+			  <td> 5</td>
+		  </tr>
+	  </table>
+  </div>
+  <div id="floatleft">
+	  <table class="tabelle">
+		  <tr>
+			  <th> NaCl [mM] </th>
+			  <th> MgCl2 [mM]</th>
+		  </tr>
+		  <tr>
+			  <td> 90 </td>
+			  <td> 30</td>
+		  </tr>
+		  <tr>
+			  <td> 90 </td>
+			  <td> 20</td>
+		  </tr>
+		  <tr>
+			  <td> 90 </td>
+			  <td> 10</td>
+		  </tr>
+		  <tr>
+			  <td> 90 </td>
+			  <td> 5</td>
+		  </tr>
+	  </table>
+  </div>
+  <div id="floatleft">
+	  <table class="tabelle">
+		  <tr>
+			  <th> NaCl [mM] </th>
+			  <th> MgCl2 [mM]</th>
+		  </tr>
+		  <tr>
+			  <td> 60 </td>
+			  <td> 30</td>
+		  </tr>
+		  <tr>
+			  <td> 60 </td>
+			  <td> 20</td>
+		  </tr>
+		  <tr>
+			  <td> 60 </td>
+			  <td> 10</td>
+		  </tr>
+		  <tr>
+			  <td> 60 </td>
+			  <td> 5</td>
+		  </tr>
+	  </table>
+  </div>
+<div>
+	<table class="imgtxt">
+		<tbody><tr>
+			<td> <img id="bild" src="https://static.igem.org/mediawiki/2013/8/80/Figure8Freiburg2013.PNG" width="750px"> </td>
+		</tr>
+		<tr>
+			<td> <b>The figure shows that the binding behaviour of the Cas9 / crRNA towards EMX1 display similar behaviour for descending MgCl2. This is true for all four NaCl concentrations however 150 mM NaCl has the smallest yield.</b></td>
+		</tr>
+	</tbody></table>
+</div>
+<div id="tag">
+<h2> 17.06.13 </h2>
+	<h3> Seeding cells for PEI transfection </h3>
+<p> The seeding of the cell was done as mentioned above. </p>
+</div>
+<div id="tag">
+<h2> 18.06.13 </h2>
+	<h3> PEI transfection and coating of ELISA plate </h3>
+<p> The PEI transfection was performed with the corresponding plasmids and coating of the ELISA plate was done as mentioned above. </p>
+</div>
+<div id="tag">
+<h2> 19.06.13 </h2>
+	<h3> Testing of dCas9 – VP16 fusion proteins in different buffer conditions </h3>
+<p> The ELISA was performed as mentioned above. The transfected HEK–293T cells were harvested using the dilution buffers with varying NaCl and varying MgCl2 contrations (10 mM Tris, 1 % BSA, 150 mM, 120 mM, 90 mM or 60 mM NaCl and 20 mM, 10 mM or 5 mM MgCl2) containing EDTA free Protease inhibitor.
 </p>
+ <div id="floatleft">
+	  <table class="tabelle">
+		  <tr>
+			  <th> NaCl [mM] </th>
+			  <th> MgCl2 [mM]</th>
+		  </tr>
+		  <tr>
+			  <td> 150 </td>
+			  <td> 5 </td>
+		  </tr>
+		  <tr>
+			  <td> 120 </td>
+			  <td> 20</td>
+		  </tr>
+		  <tr>
+			  <td> 120 </td>
+			  <td> 10</td>
+		  </tr>
+		  <tr>
+			  <td> 120 </td>
+			  <td> 5</td>
+		  </tr>
+                 <tr>
+			  <td> 90 </td>
+			  <td> 5</td>
+		  </tr>
+                 <tr>
+			  <td> 60 </td>
+			  <td> 5</td>
+		  </tr>
+	  </table>
+  </div>
+<div>
+	<table class="imgtxt">
+		<tbody><tr>
+			<td> <img id="bild" src="https://static.igem.org/mediawiki/2013/4/46/Philipp_Warmer_uniBAssVEGF123-team_freiburg.PNG
+" width="700px"> </td>
+		</tr>
+		<tr>
+			<td> Three different VEGF crRNA targets of Cas9 - VP16. The binding affinity of the Cas9 – crRNA complex was analysed during an ELISA. The figure shows that for different crRNAs the binding affinities differs. The best binding condition was obtained with 5 mM MgCl2 and 90 mM NaCl. The error bars represent the standard deviation of 3 replicas.</td>
+		</tr>
+	</tbody></table>
+</div>
+<div id="tag">
+<h2> 23.06.13 </h2>
+	<h3> Seeding cells for PEI transfection </h3>
+<p> The seeding of the cell was done as mentioned above. </p>
+</div>
+<div id="tag">
+<h2> 24.06.13 </h2>
+	<h3> PEI transfection and coating of ELISA plate </h3>
+<p> The PEI transfection was performed with the corresponding plasmids and coating of the ELISA plate was done as mentioned above. </p>
+</div>
+<div id="tag">
+<h2> 25.06.13 </h2>
+	<h3> Testing of different dCas9 fusion proteins in the optimized buffer condition.  </h3>
+<p> The tested constructs can be divided into two groups. The Cas9 fusion constructs Cas9 - VP16, Cas9 - KRAB and the Cas9 with one active nickase domain and with two nickase domains. The composition of this experiment aimed to examine whether all constructs are expressed in the same pace and display the same binding behavior.
+</p>
+<p> The ELISA was performed as explained. The ELISA indicated that the fusion constructs are 3 - fold less expressed than the constructs with the Cas9 only. The comparison between a Cas9 completely lacking the nickase activity and a Cas9 having one active nickase shows no significant difference. However the yield of the Cas9 construct without any nicking activity is slightly higher.
+A Bradford assay was used to adjust the FM protein concentration for the standard. The FM protein was coated in a 1 : 1 dilution row for 1 h at RT in duplicates onto the ELISA plate. The transfected HEK–293T cells were harvested using the optimized dilution buffer (10 mM Tris, 1 % BSA, 90 mM NaCl, 5 mM MgCl2) containing EDTA free Protease inhibitor.
+</p>
+<div>
+	<table class="imgtxt">
+		<tbody><tr>
+			<td> <img id="bild" src="https://static.igem.org/mediawiki/2013/2/2c/Figure15dFreiburg2013.PNG" width="650px"> </td>
+		</tr>
+		<tr>
+			<td> The four different biotinylated and annealed oligonucleotides (oIG9004 / oIG9005, oIG9012 / oIG9013, oIG9041 / oIG9042 and oIG9015 / oIG9016 (10 pmol / well) were coated by incubation at RT for 1 h. After 24 h transfected HEK-293T cells were resuspended in the optimized buffer condition and the binding affinity of the different Cas9 / crRNA construct was analysed during an ELISA. A quantification of the different Cas9 constructs was performed by using a standard dilution row with FM protein. a) Concentration of the undiluted Cas9 constructs. The figure shows the different quantities of different Cas9 constructs as well as the disparity of undiluted sample compared to diluted samples. Error bars represent the standard deviation of 3 replicas. </td>
+		</tr>
+	</tbody></table>
+</div>
+<div>
+	<table class="imgtxt">
+		<tbody><tr>
+			<td> <img id="bild" src="https://static.igem.org/mediawiki/2013/0/07/Figure15uFreiburg2013.PNG" width="650px"> </td>
+		</tr>
+		<tr>
+			<td> The four different biotinylated and annealed oligonucleotides (oIG9004 / oIG9005, oIG9012 / oIG9013, oIG9041 / oIG9042 and oIG9015 / oIG9016 (10 pmol / well) were coated by incubation at RT for 1 h. After 24 h transfected HEK-293T cells were resuspended in the optimized buffer condition and the binding affinity of the different Cas9 / crRNA construct was analysed during an ELISA. A quantification of the different Cas9 constructs was performed by using a standard dilution row with FM protein. Concentration of the 1:1 diluted Cas9 constructs. The figure shows the different quantities of different Cas9 constructs as well as the disparity of undiluted sample compared to diluted samples. Error bars represent the standard deviation of 3 replicas. </td>
+		</tr>
+	</tbody></table>
+</div>
+<div id="standardcurve">
+<p id="h4">
+Quantification of Cas9 via HA-tagged FM protein
+</p>
+</div>
+<p>
+to quantify the amount of Cas9 with uniBAss HA-tagged FM protein with known protein concentration. like this  we were abele to performe a dilution row to get a standard to convert the ABTS readout in ng protein bound in the ELISA.
+<div>
+	<table class="imgtxt">
+		<tbody><tr>
+			<td> <img id="bild" src="https://static.igem.org/mediawiki/2013/6/6e/Philipp_Warmer_uniBAssstandad-FMprotein1_team_freiburg.PNG" width="550px"> </td>
+		</tr>
+		<tr>
+			<td> graph showing the standard curve for quantification of HA-tagged protein in the uniBAss ELISA</td>
+		</tr>
+	</tbody></table>
+</div>
+<p>
+To convert the ABTS readout of uniBAss with our Cas9 and dCas9 the formula y = 0,0793x + 0,0255 was used. Like this we succeded in receiving absolut ng of dCas9 with our ELISA.
+</p>
+<div>
+	<table class="imgtxt">
+		<tbody><tr>
+			<td> <img id="bild" src="https://static.igem.org/mediawiki/2013/e/e8/Philipp_Warmer_uniBAss-quantificationlila1_team_freiburg.PNG" width="650px"> </td>
+		</tr>
+		<tr>
+			<td> Quantification of different Cas9 and dCas9 constructs</td>
+		</tr>
+	</tbody></table>
+</div>
 <div id="july">
@@ Line 395: / Line 794: @@
 <div id="tag">
-   <h2> 23. July </h2>
+   <h2> 23.07.13 </h2>
 	<h3> PCR Cas9 </h3>
    <div id="floatleft">
@@ Line 467: / Line 866: @@
 <div id="tag">
-   <h2> 24. July </h2>
+   <h2> 24.07.13 </h2>
    <h3> PCR Cas9 </h3>
    <p> PCR was repeated with same program but 25 cycles instead of 18. This time no unspecific bands were visible (picture could not be saved). Both bands were cut out and extracted over same column with Roche Kit. <br>
@@ Line 561: / Line 960: @@
 <div id="tag">
-   <h2> 25. July </h2>
+   <h2> 25.07.13 </h2>
    <h3> Ligation of digested Cas9-PCR product and dIG6000 </h3>
    <h4> Calculation: </h4>
@@ Line 599: / Line 998: @@
 	    	</tr>
      </table>
+</div>
    <p> 30min at 22&deg;C <br> </p>
@@ Line 613: / Line 1,013: @@
 <div id="tag">
-   <h2> 26. July </h2>
+   <h2> 26.07.13 </h2>
    <h3> Miniprep of colonies 1-4 </h3>
-   <li>with Roche kit.</li> <br>
+   <li> with Roche kit. </li> <br>
    <div id="floatleft">
@@ Line 673: / Line 1,073: @@
        <li> expected fragments: </li>
        <ol>
-         <li>4826bp for Cas9-KRAB-bgh</li>
+         <li> 4826bp for Cas9-KRAB-bgh </li>
-         <li>2722bp for pSB1C3-CMV (dIG6000) </li>
+         <li> 2722bp for pSB1C3-CMV (dIG6000) </li>
        </ol>
 	  </ul>
@@ Line 685: / Line 1,085: @@
 	    	</tr>
 	    	<tr>
-	    		<td>Roth marker, mini1, 2, 3, 4, pIG6000 <br>
+	    		<td> Roth marker, mini1, 2, 3, 4, pIG6000 <br>
   Cas9-KRAB (4826bp) pIG6000 (upper band 2721bp, insert 1064bp) <br>
-in mini2 slight Cas9 band is visible (marked by star).</td>
+in mini2 slight Cas9 band is visible (marked by star). </td>
 	    	</tr>
 	  </table>
@@ Line 699: / Line 1,099: @@
 <div id="tag">
-   <h2> 27. July </h2>
+   <h2> 27.07.13 </h2>
    <h3> Test-PCR on Mini2 for Truncation 2 </h3>
    <p> fw: oIG9032 rev: oIG9033 <br>
@@ Line 713: / Line 1,113: @@
    <h3> Mini preps of ligation colonies 5-7 and 2&4 again to yield higher concentrations </h3>
-   <div id="floatleft">
+   <div>
      <table class="tabelle">
        <tr>
@@ Line 736: / Line 1,136: @@
    <h3> Test digest of Minis with SacII and KpnI </h3>
    <p> For protocol see 26.7.13. 1&micro;l of each Mini prep was used. <br>
-  <br>
    </p>
@@ Line 768: / Line 1,167: @@
 <div id="tag">
-   <h2> 29. July </h2>
+   <h2> 29.07.13 </h2>
    <h3> Truncation PCRs </h3>
    <p> annealing: 64&deg;C <br>
@@ Line 790: / Line 1,189: @@
 <div id="tag">
-	<h2> 30. July </h2>
+	<h2> 30.07.13 </h2>
 	<p> Truncation 3 and 4 yielded 10-15 colonies each. No colonies on other plates. 8 			colonies from each plate were picked and streaked out for mini preps.
 	</p>
@@ Line 832: / Line 1,231: @@
 <div id="tag">
-	<h2> 31. July </h2>
+	<h2> 31.07.13 </h2>
    <h3> Mini preps and test digest of truncation 3 and 4 </h3>
 	<p> Minis: >200ng/&micro;l, 1&micro;l was digested with EcoRI and SpeI (both HF) for 2h at 37&deg;C. </p>
@@ Line 883: / Line 1,282: @@
 <div id="tag">
-	<h2> 6.8. </h2>
+	<h2> 06.08.13 </h2>
 	<h3> Seeding cells for transfection </h3>
-	<p> 120000cells/ml were seeded in six well plates (3ml per well)
+	<p> 120,000cells/ml were seeded in six well plates (3ml per well)
 	</p>
@@ Line 895: / Line 1,294: @@
 <div id="tag">
-	<h2> 7.8. </h2>
+	<h2> 07.08.13 </h2>
 	<h3> Inoculate Midis for T1, 2, 5, pIG9100(Cas9), pIG3010(EMX1, EGFP) </h3>
 	<p> 100ml LB + 100&micro;l Chloramphenicol. For T2 four additional minis were inoculated for midi and sent for overnight sequencing.
@@ Line 905: / Line 1,304: @@
 <div id="tag">
-	<h2> 8.8. </h2>
+	<h2> 08.08.13 </h2>
 	<h3> Midipreps of plasmids </h3>
 	<p> All plasmids were prepped because sequencing was delayed. Concentrations: ?
@@ Line 923: / Line 1,322: @@
 <div id="tag">
-	<h2> 9.8. </h2>
+	<h2> 09.08.13 </h2>
 	<h3> Cell lysis and ELISA (Fenja and Philipp)</h3>
 	<p> did not work; repeat everything.
@@ Line 931: / Line 1,330: @@
 <div id="tag">
-   <h2> 12.8. </h2>
+   <h2> 12.08.13 </h2>
    <h3> Cell Seeding </h3>
-   <p> x cells/ml seeded in 6 well plate
+   <p> aprox. 65,000 cells/ml seeded in 6 well plates.
    </p>
-   <h3> Sequencing Results for T2 </h3>
+   <h3> Sequencing Results for Truncation 2 </h3>
    <p> T2.3 is positive
    </p>
@@ Line 941: / Line 1,340: @@
 <div id="tag">
-   <h2> 13.8. </h2>
+   <h2> 13.08.13 </h2>
    <h3> Transfection </h3>
-   <p> Natalie, scheme
+   <p> Natalie transfected  the truncations (two 6-wells)
    </p>
-   <h3> ELISA II </h3>
+   <h3> uniBAss II </h3>
-   <p> Coating plate
+   <p> Coating plate with streptavidin
    </p>
 </div>
 <div id="tag">
-   <h2> 14.8. </h2>
+   <h2> 14.08.13 </h2>
    <h3> Cell lysis </h3>
-   <p> with dilution buffer (500&micro;l per 6-well) and sonification (10min)
+   <p> With dilution buffer (500&micro;l per 6-well) and sonification (10min)
    </p>
-   <h3> ELISA II </h3>
+   <h3> uniBAss II </h3>
-   <p> loading scheme? <br> ELISA did not work. Secondary antibody broken? Try again..
+   <p>  Triplicates of the probes were run on the plate but the ELISA did not work. It´s hard to say why we could not detect bound dCas9. Secondary antibody broken? Try again..
    </p>
 </div>
 <div id="tag">
-   <h2> 15.8. </h2>
+   <h2> 15.08.13 </h2>
    <h3> Cell Seeding </h3>
+   <p> approx. 65,000 cells/ml seeded in 6 well plates.
+   </p>
 </div>
 <div id="tag">
-   <h2> 16.8. </h2>
+   <h2> 16.08.13 </h2>
    <h3> Transfection </h3>
-   <p> PIF-GFP as transfection control
+   <p> PIF-GFP served as a transfection control.
    </p>
 </div>
 <div id="tag">
-   <h2> 17.8. </h2>
+   <h2> 17.08.13 </h2>
-   <h3> ELISA III </h3>
+   <h3> uniBAss III </h3>
-   <p> no Cas9 in pSB1C3 detectable. Test if Cas is expressed: Western Blot with remaining cell lysat against HA-tag.
+   <p> No dCas9 in pSB1C3 detectable. Test if dCas is expressed: Western Blot with remaining cell lysate against HA-tag.
    </p>
+<div>
+	        	<table class="image">
+	        		<tr>
+	        			<td> <img class="image" src="https://static.igem.org/mediawiki/2013/5/59/Freiburg_2013_uniBAss_results_170813.png"> </td>
+	        		</tr>
+	        		<tr>
+	        			<td> Results of uniBAss ELISA experiment</td>
+	        		</tr>
+	        	</table>
+	    </div>
 </div>
 <div id="tag">
-   <h2> 18.8. </h2>
+   <h2> 18.08.13 </h2>
    <h3> Cell lysis and Blot</h3>
    <p> Done at AG Warscheid. anti-HA antibody overnight.
@@ Line 989: / Line 1,399: @@
 <div id="tag">
-   <h2> 19.8. </h2>
+   <h2> 19.08.13 </h2>
    <h3> Detection of blot </h3>
-   <p> anti-mouse antibody (xh), washing steps, detection with ECL. illumination for 1000sec, only unspecific bands. Repeat western Blot: transfection, lysis, SDS PAGE, blot.
+   <p> Anti-mouse antibody (xh), washing steps, detection with ECL. illumination for 1000sec, only unspecific bands. Repeat western Blot: transfection, lysis, SDS PAGE, blot.
    </p>
    <h3> Cell seeding and transfection </h3>
-   <p> HEK293-H from Adrian were seeded and transfected 5?h afterwards.
+   <p> HEK-293H from Adrian were seeded and transfected 5h afterwards.
    </p>
 </div>
 <div id="tag">
-   <h2> 20.8. </h2>
+   <h2> 20.08.13 </h2>
-   <p> Transfection did not work. Seed new cells.
+   <p> Transfection did not work, the cells died because they did not tolerate the transfection only a few hours after seeding. We therefore seeded new cells.
    </p>
@@ Line 1,006: / Line 1,416: @@
 <div id="tag">
-   <h2> 21.8. </h2>
+   <h2> 21.08.13 </h2>
    <h3> Transfection </h3>
-   <p> let cells grow for 48h! Medium change after 5h.
+   <p> Transfection was performed by Lisa and we let cells grow for 48h! Medium change after 5h.
    </p>
@@ Line 1,014: / Line 1,424: @@
 <div id="tag">
-   <h2> 22.8. </h2>
+   <h2> 22.08.13 </h2>
    <h3> SDS gels </h3>
-   <p>
+   <p> For the westernblot tomorrow SDS gels were poured with the invitrogen system.
    </p>
@@ Line 1,022: / Line 1,432: @@
 <div id="tag">
-   <h2> 23.8. </h2>
+   <h2> 23.08.13 </h2>
    <h3> Cell Lysis </h3>
-   <p> with modified RIPA buffer from Adrian (200&micro;l per 6-well), incubated on ice 10min, scraped off with pipet tip, in eppi, on ice for 5-10min, centrifuge 5min, 10000xg. <br> boil 150&micro;l lysate with 50&micro;l 4x sample buffer (5min, 95&deg;C)
+   <p> Cell lysis was performed with modified RIPA buffer (200&micro;l per 6-well), incubated on ice 10min, scraped off with pipet tip, in eppi, on ice for 5-10min, centrifuge 5min, 10000xg. <br> boil 150&micro;l lysate with 50&micro;l 4x sample buffer (5min, 95&deg;C).
    </p>
    <h3> SDS PAGE </h3>
-   <p>
+   <p> The probes were loaded onto the gel.
    </p>
    <h3> Western Blot </h3>
-   <p> anti-HA mouse 1:2000 (AG Weber) in TBS with BSA.
+   <p> Semidry western blot was performed and after blocking anti-HA mouse 1:2000 (AG Weber) in TBS with BSA was applied over night.
    </p>
 </div>
 <div id="tag">
-   <h2> 24.8. </h2>
+   <h2> 24.08.13 </h2>
-   <h3> detection </h3>
+   <h3> Detection </h3>
-   <p> secondary antibody (1.5&micro;l anti-mouse in 25ml TBS), wash for 2h..
+   <p> Secondary antibody (1.5&micro;l anti-mouse in 25ml TBS), wash for 2h..
    </p>
-   <p> still no cas9 in pSB1C3! </p>
+   <p> Still no dCas9 in pSB1C3! </p>
 </div>
-<div id="tag">
-  <h2> 25.08-28.08.13 </h2>
-  <h3> Natalie: Cas9-mCherry? </h3>
-</div>
 <div id="tag">
    <h2> 29.08.13 </h2>
    <h3> Truncation PCRs with standardized Cas9 (CMV-HA-NLS-Cas9-bGH) </h3>
-   <p> all PCRs were done as on 29.07.13 with 4min elongation time and 64 &deg;C annealing temperature. All PCRs worked.
+   <p> All PCRs were done as on 29.07.13 with 4min elongation time and 64 &deg;C annealing temperature. All PCRs worked.
    </p>
    <div>
@@ Line 1,147: / Line 1,552: @@
    <p> All midi-prepped plasmids were transfected (6well protocol, 3&micro;g total DNA) with pIG9000, PIF-GFP and pIG2004 as controls. This transfection will be used for western blotting to see if the standardized Cas9 is expressed in pSB1C3.
    </p>
+<div>
+	        	<table class="image">
+	        		<tr>
+	        			<td> <img class="image" src="https://static.igem.org/mediawiki/2013/d/d2/Freiburg_2013_uniBAss_transfection_010913.png"> </td>
+	        		</tr>
+	        		<tr>
+	        			<td> Transfection scheme for uniBAss ELISA experiment</td>
+	        		</tr>
+	        	</table>
+	    </div>
 </div>
@@ Line 1,155: / Line 1,570: @@
    </p>
    <h3> Cells seeded for ELISA </h3>
-   <p> 65000 cells/well were seeded in 6-well plates as transfection will only be on wednesday (04.09.).
+   <p> 65,000 cells/well were seeded in 6-well plates as transfection will only be on wednesday (04.09.).
    </p>
 </div>
@@ Line 1,177: / Line 1,592: @@
    <p> retrafo and new minis (in 1.5ml eppis) of T1-5? Natalie.
    </p>
+<h3> Transfection of pIG9200 truncations with EMX1-RNA Plasmid </h3>
+<div>
+	        	<table class="image">
+	        		<tr>
+	        			<td> <img class="image" src="https://static.igem.org/mediawiki/2013/1/11/Freiburg_2013_uniBAss_transfection_040913.png"> </td>
+	        		</tr>
+	        		<tr>
+	        			<td> Transfection scheme for uniBAss ELISA experiment</td>
+	        		</tr>
+	        	</table>
+	    </div>
 </div>
@@ Line 1,330: / Line 1,757: @@
    <h2> 22.09.13 </h2>
    <h3> Seeding cells </h3>
-   <p> 4 6well plates were seeded with 130000cells/ml=260000cells/well.
+   <p> Four 6-well plates were seeded with 130,000cells/ml=260,000cells/well.
    </p>
    <h3> Midis inoculated </h3>
@@ Line 1,342: / Line 1,769: @@
    <p> Finally sequencing results were correct (T4 was repeated:check tomorrow), inoculated midis were prepped with Promega kit (double buffer amounts) and eluted in 600&micro;l nuclease free H<sub>2</sub>O.
    </p>
-   <p> Transfection was performed as on plan in 6well plates. Additionally all standardized constructs (CMV and SV40) and their non-standardized pX334a-versions were transfected to be compared on uniBAss. The Assay will be performed 48h after transfection. change of media required? check in the morning!
+   <p> Transfection was performed as on plan in 6-well plates. Additionally all standardized constructs (CMV and SV40) and their non-standardized pX334a-versions were transfected to be compared on uniBAss. The Assay will be performed 48h after transfection. change of media required? check in the morning!
    </p>
+  <div id="transfection1234">
+	        	<table class="image">
+	        		<tr>
+	        			<td> <img class="image" src="https://static.igem.org/mediawiki/2013/8/84/Freiburg_2013_uniBAss_transfection_230913.png"> </td>
+	        		</tr>
+	        		<tr>
+	        			<td> Transfection scheme for uniBAss ELISA experiment</td>
+	        		</tr>
+	        	</table>
+	    </div>
 </div>
 <div id="tag">
    <h2> 24.09.13 </h2>
-	<p> No medium change of the cells transfected the day before was performed. SDS-Gel for the westernblot which will be performed tomorrow poured. the ELISA plate for uniBAss is coated with strepdadivin.
+	<p> No medium change of the cells transfected the day before was performed. SDS-Gel for the westernblot which will be performed tomorrow poured. The ELISA plate for uniBAss is coated with streptadivin.
 	</p>
 	</div>
 <div id="tag">
    <h2> 25.09.13 </h2>
-   <h3> uniBAss Day</h3>
+   <h3> uniBAss ELISA </h3>
-   <p> The HEK cells were lysed  about 42h after transfection. the uniBAss ELISA was performed as in the protocol. in parallel a westernblot was performed with 2/5 of the lysate of each well to ensure Cas9 expression.
+   <p> The HEK-293T cells were lysed about 42h after transfection. The uniBAss ELISA was performed according to the protocol. In parallel a westernblot was performed with 2/5 of the lysate of each well to ensure dCas9 expression.
    </p>
+	<h2> 25.09.13 </h2>
+		<h3> Westernblot of uniBAss probes</h3>
+			<p> The westernblot of yesterday was analyzed. Due to problems with resolving the protein pellet we had suboptimal results in the blot.</p>
+<p>
+  Therefore we want to repeat the hole experiment. As two days before we transfected HEK-293T cells in 6-wells: <a id="link" href="#transfection1234">transfection scheme</a>. This time we made biological duplicates for the standardised constructs. (together six 6-wells)  </p>
+</div>
+<div id="tag">
+	<h2> 26.09.13 </h2>
+	<p> Medium of the six 6 wells was exchanged 12h after transfection.
+	</p>
 </div>
+<div id="tag">
+	<h2> 27.09.13 </h2>
+	<h3> Westernblot of 2. uniBAss probes</h3>
+	<p> As an expression control we wanted to perform the westernbot of the transfected cells this time before we to the uniBAss ELISA. So we collected the cells in 500&micro;l diluent buffer and took 170&micro;l for western blotting. The 170&micro;l cell suspension was centrifuged for 5min at 10,000xg, the supernatant decanted and the pellet resuspended in 100&micro;l SDS-sample buffer. Then the suspension was sonified for a total of 35min. The probes were cooked for 15min and SDS-page was performed, followed by a semidry westernblot. After blocking, the primary antibody (mouse-anti-HA) was applied over night. </p>
+</div>
+<div id="tag">
+	<h2> 28.09.13 </h2>
+	<p> Development of the westernblot. After washing and applying the secondary antibody we developed the membranes. </p>
+<img src="https://static.igem.org/mediawiki/2013/f/f7/UniBAssblotfertig1.1.PNG" width="700px">
+<br>
+<img src="https://static.igem.org/mediawiki/2013/0/04/UniBAssblotfertig2.1-team_Freiburg.PNG" width="700px">
+<br>
+<div id="western_blot_data">
+	        	<table width="800px">
+	        		<tr>
+	        			<td> <img src="https://static.igem.org/mediawiki/2013/7/78/UniBAssblotfertig3.1-team_Freiburg.PNG" width="800px"> </td>
+	        		</tr>
+	        	</table>
+	    </div>
+<p> We could detect most of our constructs and had very nice bands. So we want to perform the uniBAss with all our probes tomorrow, therefore we coated an ELISA plate with streptavidin.
+</p>
+</div>
+<div id="tag">
+	<h2> 29.09.13 </h2>
+	<h3> uniBAss ELISA V</h3>
+	<p> To perform the uniBAss we had to unfreeze our probes from the -80&deg;C freezer. Then we sonified them and proceeded with our usual uniBAss-protocol.  Except for the constructs containing a CAG promoter all constructs are standardized and in pSB1C3. CMV-GFP serves as a negative control as it contains no dCas9 (and thus no HA-tag), CMV-dCas9 neg contains no RNAimer plasmid and also should not be able to bind the EMX1 oligo. As a control for specificity of the binding we coated one well for each construct without any oligo and an additional well with a VEGF oligo that is not complementary to the EMX1 target site on the RNAimer that was co-transfected with all dCas9-constructs.
+</p>
+<div id="uniBAss-unnormalized">
+	        	<table width="800px">
+	        		<tr>
+	        			<td> <img src="https://static.igem.org/mediawiki/2013/2/28/UnibassnooligocontrolnormalisierungNatalie-Lisa-Team_Freiburg.png" width="800px"> </td>
+	        		</tr>
+	        	</table>
+	    </div>
+<p>We received lower ABTS readouts for our dCas9 fusion constructs than for the dCas9 alone. But is due to significant weaker expression of the fusion-constructs. Therefore we normalized the values of the ABTS readout in the ELISA to the dCas9 amount with the help of the westernblot of the respective contructs. We substracted the no oligo values and then set the dCas9 alone to 100% expression.For the dCas9-VP16 construct we received a value of 25,6% expression after analysis with imageJ. For dCas9-KRAB 5,4% and for dCas9-G9a 53,7%.  Errorbars show the standard deviation of two technical replicates.
+</p>
+<div>
+	        	<table width="800px">
+	        		<tr>
+	        			<td> <img src="https://static.igem.org/mediawiki/2013/5/5b/UnibasswbnormalisierungNatalie-Lisa33333.png" width="800px"> </td>
+	        		</tr>
+	        	</table>
+	    </div>
+<div>
+	        	<table width="800px">
+	        		<tr>
+	        			<td> <img src="https://static.igem.org/mediawiki/2013/a/a5/Freiburg_2013_uniBAss_results_290913.png" width="800px"> </td>
+	        		</tr>
+	        		<tr>
+	        			<td> uniBAss ELISA results 29.09.13. </td>
+	        		</tr>
+	        	</table>
+	    </div>
+<p> Again only the non-standardized constructs show an ABTS signal, meaning that no dCas9 binding is detected in our standardized pSB1C3 constructs. This is probably due to the low expression of CMV-dCas9 and SV40-dCas9 we observed in the western blot which might not be sufficient to be detected with uniBAss. For the other oligo control we see strange off target effects that are probably due to a technical mistake. Maybe our BSA batch is not working properly as we get too high values for unspecific binding. The results show non the less that there is no binding detected for negative controls lacking dCas9 or the RNAimer plasmid.
+</p>
+<p> After evaluating the results of the assay we desided to repeat the experiment one more time. Next time we will try to use more cell lysate to get higher amounts of dCas9 protein so that effects for the dCas9 in pSB1C3 can be seen in uniBAss. Therefore four 6-well plates HEK-293T cells are seeded which will be transfected tomorrow. We will try the following changes in our uniBAss protocol: </p>
+<ol> <li> Transfection in duplicates to gain more volume of lysate </li>
+<li> take up cells in 100-200&micro;l dilution buffer per 6-well to obtain higher dCas9 concentration in lysates </li>
+<li> sonify cells for 10min </li>
+<li> centrifuge lysate before applying it to the 96-well ELISA plate to get rid of cell debris </li>
+<li> increase oligo concentration when coating the wells </li>
+<li> try a different off-target oligo from AG Weber </li>
+</ol>
+</div>
+<div id="tag">
+	<h2> 30.09.13 </h2>
+	<h3> Transfection</h3>
+	<p> This time we transfected only the standardized constructs but in biological duplicate to have enough cell lysate for uniBAss. Ilona did the transfection of the four 6-well plates.
+</p>
+ </div>
+<div id="october">
+<p id="h2">
+October
+</p>
+</div>
+<div id="tag">
+	<h2> 01.10.13 </h2>
+	<p> New 10xTBS was made and the uniBAss ELISA plate was coated with streptavidin.
+</p>
+ </div>
+<div id="tag">
+	<h2> 02.10.13 </h2>
+	<h3> last but not least uniBAss</h3>
+	<p> Today we performed the last trial to get results with uniBAss with the standardized constructs before the Jamboree in Lyon.
+</p>
+<p> The ELISA plate well were blocked and coated with oligos (EMX1, other oligo from AG Weber, no oligo). Then wells were blocked again with blocking buffer containing new BSA (Sigma). Cells were scraped off in 160&micro;l dilution buffer (also with new BSA) per 6-well, sonified for 10min at 4&deg;C and centrifuged 5min at 500xg. 100&micro;l of lysate was applied to each well and incubated for more than 1h. Afterwards the standard protocol was followed.
+</p>
+<p> All efforts taken to upconcentrate the amount of dCas9 in pSB1C3 were not enough to see an effect in uniBAss. Due to a lack of time we will not repeat the uniBAss again.
+<p>
+ </div>
+<h2>06.10.13</h2>
+  <h3>Seeding of cells for functional test of all truncations</h3>
+<p>2 24-well plates were seeded with 65,000 cells per well.</p>
+<h2>07.10.13</h2>
+  <h3>Transfection</h3>
+One plate was transfected with a reporter plasmid containing SEAP under the control of a CMVmin promoter, differnently truncated dCas9-VP16 constructs
+and two RNA plasmids (activation via VP16); the other with a reporter plasmid containing SEAP under the control of a SV40 promoter, differnently
+truncated dCas9 constructs and two RNA plasmids (repression via CRISPRi).
+<ol>
+<li>40 µl Opti-MEM + 0.75 µg of the DNA of interest were mixed in a 1.5 ml Eppi.</li>
+<li>Addition of 2.25 µl PEI-solution, vortexing for 10 s and incubation for at least 15 min at RT.</li>
+<li>Solution was spread drop-wise to the cells in the dish</li>
+</ol>
+<p>Ratio of DNA amount (mass): <br>
+reporter plasmid (SEAP) : effector plasmid (Cas9) : RNA plasmid<br>
+: 4 : 4 <br>
+Additionally a plasmid coding for Renilla luciferase was cotransfected (5 % of DNA amount)</p>
+<h2>08.10.13</h2>
+  <h3>Medium change</h3>
+Medium was changed after 12 h.
+<h2>09.10.13</h2>
+   <h3>Medium removal</h3>
+<ul>
+<li>Supernatant was collected for SEAP measurement 36 h after transfection for repression and 46 h after transfection for activation.</li>
+<li>Cells of repression were frozen at - 80 °C for later on Renilla measurement.</li>
+</ul>
+  <h3>SEAP measurement of repression</h3>
+<ul>
+<li>Collected supernatant and fresh cell culture medium was heated at 65 °C for 30 min, then centrifuged at 1250 g for 1 min.</li>
+<li>Supernatant was diluted in cell culture medium 1:5 and 1:10.</li>
+<li>80 µl of (diluted) supernatant was applied to 100 µl of SEAP buffer.</li>
+<li>After addition of 20 µl pNPP (substrate of SEAP) the absorbance of the mix was measured every minute for 2 h at 405 nm.
+</ul>
+  <h3>SEAP measurement of activation</h3>
+<ul>
+<li>Collected supernatant and fresh cell culture medium was heated at 65 °C for 30 min.</li>
+<li>80 µl of supernatant was applied to 100 µl of SEAP buffer.</li>
+<li>After addition of 20 µl pNPP (substrate of SEAP) the absorbance of the mix was measured every minute for 2 h at 405 nm.
+</ul>
+  <h3>Cell lysis for lyciferase measurement</h3>
+<ul>
+<li>250 µl of lysis buffer (containing Tris-HCl, EGTA, MgSO<sub>4</sub>, DTT and protease inhibitor) were applied to the (thawn) cells of each well.</li>
+<li>Incubation on ice for at least 10 min.</li>
+<li>Centrifugation at 2,200 g for 15 min.</li>
+</ul>
+  <h3>Luciferase luminescence measurement</h3>
+<ul>
+<li>80 µl of supernatant were pipetted in a white 96 well plate.</li>
+<li>Measurement of luminescence (every 2 min for 15 min) immediately after addition of 20 µl Renilla substrate in PBS.</li>
+</ul>
+<div>
+	<table class="imgtxt" width="800px">
+		<tr>
+			<td> <img class="imgtxt" width="800px"
+src="https://static.igem.org/mediawiki/2013/0/08/Truncation_activation_I_Freiburg_2013.png"> </td>
+		</tr>
+		<tr>
+			<td> <b>Results of activation via VP16</b><br>
+Truncation clearly activated SEAP expression, but afterwards sequencing revealed that the truncation did not work. So T4 is actually the same as the
+positive control.
+			</td>
+		</tr>
+	</table>
+</div>
+<div>
+	<table class="imgtxt" width="800px">
+		<tr>
+			<td> <img class="imgtxt" width="800px"
+src="https://static.igem.org/mediawiki/2013/a/a2/Truncation_CRISPRi_Freiburg_2013.png"> </td>
+		</tr>
+		<tr>
+			<td> <b>Results of repression via CRISPRi</b><br>
+After normalization to Renilla expression the positive and the negative controls had almost the same values. So there can not be drawn a validated
+conclusion from this experiment. Nevertheless it is conspicuous that the SEAP level of truncation 4 is clearly below the ones of 2, 3 and 5.
+			</td>
+		</tr>
+	</table>
+</div>
+<h2>10.10.13</h2>
+<p>Digestion of uniCAS Truncation 4 with EcoRI and AgeI. Simultaneous digestion of G9a, Krab, KrabKrab, VP16, VP32, VP64 in RFC25 standard with NgoMIV and SpeI. Additionally, digestion of the BgH terminator in RFC10 with XbaI and EcoRI. Subsequent ligation of three fragments each. uniCas Truncation 4 and BgH terminator fragments were the same for all plasmids, whereby only the effector domains were exchanged among the constructs to-be cloned.</p>
+<h2>14.10.13</h2>
+<p> Striking out of four colonies per attempt: uniCAS T4-VP16, uniCAS T4-VP32, uniCAS T4-VP64, uniCAS T4-Krab, uniCAS T4-KrabKrab and uniCAS T4-G9a. </p>
+<h2>15.10.13</h2>
+<p> Miniprep of clones. Testdigest with NotI. All constructs have shown positive digest results, except for uniCAS T4-VP32.</p>
+<div>
+	  <table class="gelpic">
+		  <tr>
+		    	<td> <img class="gelpic" src="https://static.igem.org/mediawiki/2013/d/df/Truncation_12_10.jpg"> </td>
+		  </tr>
+		  <tr>
+		    	<td> Roth 1kb marker, T4 (neg. control), T4-VP16, T4-VP64, T4-VP64, T4-Krab, T4-KrabKrab, T4-G9a, Roth 1kb marker <br><br>
+		    After NotI digestion, a ~ 600 bp band, indicating the CMV promoter became recognizable for all obtained vectors. Moreover, according to the size of the upper band, it was also obvious to detect size differences among constructs such as VP16 and VP64. </td>
+		  </tr>
+	  </table>
+  </div>
+<h2>16.10.13</h2>
+  <h3>Seeding of cells for functional test of truncation 4</h3>
+<p>2 24-well plates were seeded with 65,000 cells per well.</p>
+<h2>17.10.13</h2>
+  <h3>Transfection</h3>
+One plate was transfected with a reporter plasmid containing SEAP under the control of a CMVmin promoter, truncated dCas9-VP16 / VP64 constructs as
+well as two RNA plasmids (activation); the other with a reporter plasmid containing SEAP under the control of a CMV promoter, truncated dCas9-KRAB2 /
+G9a constructs and a RNA plasmid containing two crRNAs (repression).
+<ol>
+<li>40 µl Opti-MEM + 0.75 µg of the DNA of interest were mixed in a 1.5 ml Eppi.</li>
+<li>Addition of 2.25 µl PEI-solution, vortexing for 10 s and incubation for at least 15 min at RT.</li>
+<li>Solution was spread drop-wise to the cells in the dish</li>
+</ol>
+<p>Ratio of DNA amount (mass): <br>
+reporter plasmid (SEAP) : effector plasmid (Cas9) : RNA plasmid<br>
+: 4 : 4 <br>
+Additionally a plasmid coding for Renilla luciferase was cotransfected (5 % of DNA amount)</p>
+<h2>18.10.13</h2>
+  <h3>Medium change</h3>
+Medium was changed after 14 h.
+<h2>19.10.13</h2>
+   <h3>Medium removal</h3>
+<ul>
+<li>Supernatant was collected for SEAP measurement 36 h after transfection for repression and 46 h after transfection for activation.</li>
+<li>Cells of repression were frozen at - 80 °C for later on Renilla measurement.</li>
+</ul>
+<h2>20.10.13</h2>
+   <h3>SEAP Assay</h3>
+<div>
+	        	<table class="image">
+	        		<tr>
+	        			<td> <img class="image" src="https://static.igem.org/mediawiki/2013/6/6e/Aktivierung_Truncation_Freiburg2013.jpg"> </td>
+	        		</tr>
+	        		<tr>
+	        			<td> Results of SEAP activation via uniCAS truncation No. 4 with VP16 and VP64 effectors. An activation by the truncated constructs could not be observed - as obvious by comparing the positive control (left) with any of the vectors.</td>
+	        		</tr>
+	        	</table>
+	    </div>
+<div>
+	        	<table class="image">
+	        		<tr>
+	        			<td> <img class="image" src="https://static.igem.org/mediawiki/2013/7/7b/Reprimierung_Truncation_Freiburg2013.jpg"> </td>
+	        		</tr>
+	        		<tr>
+	        			<td> Results of SEAP repression via uniCAS truncation No. 4 with G9a and Krab effectors. Strongfold downregulation could be observed in most cases. However, as off-target repression only occurs, it can be assumed that the repressive effect does not emerge from the domains or locus-specific binding.</td>
+	        		</tr>
+	        	</table>
+	    </div>
 </div>
 </body>
 </html>